Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
63000,,Not Active,5212363,[],CHEMBL1673533,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2911 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332671,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
63001,,,5212370,[],CHEMBL1680753,"Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 33 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,4.0
63002,,,5212371,[],CHEMBL1680755,"Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 34 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,4.0
63003,,,5213059,[],CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63004,,,5213069,[],CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63005,,,5213079,[],CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63006,,,5213082,[],CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63007,,,5213090,[],CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63008,,,5213095,[],CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63009,,,5213114,[],CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63010,,,5213116,[],CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63011,,,5213119,[],CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63012,,,5213123,[],CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63013,,,5213126,[],CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63014,,,5213128,[],CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63015,,,5213131,[],CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63016,,,5213133,[],CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63017,,,5213136,[],CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63018,,,5213138,[],CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63019,,,5213146,[],CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
63020,,,5213260,[],CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,<=,1,1,<=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
63021,,,5213288,[],CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
63022,,,5213289,[],CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
63023,,,5213290,[],CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
63024,,,5213291,[],CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
63025,,,5213292,[],CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
63026,,Not Determined,5213398,[],CHEMBL1673539,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2474 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332671,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
63027,,,5214019,[],CHEMBL1674079,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.12
63028,,,5214029,[],CHEMBL1674080,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,83.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,83.9
63029,,,5214038,[],CHEMBL1674081,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,15.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,15.2
63030,,,5214048,[],CHEMBL1674082,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,8.0
63031,,,5214058,[],CHEMBL1674083,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,25.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,25.6
63032,,,5214067,[],CHEMBL1674198,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,73.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,73.2
63033,,,5214077,[],CHEMBL1674199,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.12
63034,,,5214087,[],CHEMBL1674200,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,81.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,81.6
63035,,,5214448,[],CHEMBL1677043,Antimicrobial activity against Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
63036,,,5214459,[],CHEMBL1677044,Antimicrobial activity against Streptococcus pneumoniae serotype 3 assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
63037,,,5214470,[],CHEMBL1677045,Antimicrobial activity against Streptococcus pneumoniae serotype 35B assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,,Activity,%,,98.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,98.3
63038,,,5214481,[],CHEMBL1677046,Antimicrobial activity against Streptococcus pneumoniae serotype 7F assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,,Activity,%,,98.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,98.3
63039,,,5214493,[],CHEMBL1677047,Antimicrobial activity against Streptococcus pneumoniae serotype 11A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
63040,,,5214505,[],CHEMBL1677048,Antimicrobial activity against Streptococcus pneumoniae serotype 6C assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
63041,,,5214517,[],CHEMBL1677049,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,,Activity,%,,99.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,99.2
63042,,,5214529,[],CHEMBL1677050,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,,Activity,%,,99.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,99.2
63043,,,5214541,[],CHEMBL1677051,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,,Activity,%,,99.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,99.2
63044,,,5214584,[],CHEMBL1677175,Antimicrobial activity against Streptococcus pneumoniae serotype 15A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
63045,,,5214585,[],CHEMBL1677176,Antimicrobial activity against Streptococcus pneumoniae serotype 22F assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
63046,,,5214586,[],CHEMBL1677179,Antimicrobial activity against Streptococcus pneumoniae serotype 23A assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
63047,,,5214587,[],CHEMBL1677177,Antimicrobial activity against Streptococcus pneumoniae serotype 23B assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,,Activity,%,,97.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,97.0
63048,,,5214588,[],CHEMBL1677178,Antimicrobial activity against Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332160,=,1,0,=,,Activity,%,,96.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,96.6
63049,,,5214889,[],CHEMBL1677458,Antimicrobial activity against Chlamydia trachomatis serovar F infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
63050,,,5214890,[],CHEMBL1677457,Antimicrobial activity against Chlamydia trachomatis serovar E infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
63051,,,5214891,[],CHEMBL1677456,Antimicrobial activity against Chlamydia trachomatis serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
63052,,,5214892,[],CHEMBL1677459,Antimicrobial activity against Chlamydia trachomatis serovar G infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.25
63053,,,5214893,[],CHEMBL1677460,Antimicrobial activity against Chlamydia trachomatis serovar H infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
63054,,,5214894,[],CHEMBL1677461,Antimicrobial activity against Chlamydia trachomatis serovar I infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
63055,,,5214895,[],CHEMBL1677462,Antimicrobial activity against Chlamydia trachomatis serovar J infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
63056,,,5214896,[],CHEMBL1677463,Antimicrobial activity against Chlamydia trachomatis serovar K infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
63057,,,5214897,[],CHEMBL1677464,Bactericidal activity against Chlamydia trachomatis serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.5
63058,,,5214898,[],CHEMBL1677465,Bactericidal activity against Chlamydia trachomatis serovar E infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.5
63059,,,5214899,[],CHEMBL1677466,Bactericidal activity against Chlamydia trachomatis serovar F infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.5
63060,,,5214900,[],CHEMBL1677467,Bactericidal activity against Chlamydia trachomatis serovar G infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.25
63061,,,5214901,[],CHEMBL1677468,Bactericidal activity against Chlamydia trachomatis serovar H infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.5
63062,,,5214902,[],CHEMBL1677469,Bactericidal activity against Chlamydia trachomatis serovar I infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.5
63063,,,5214903,[],CHEMBL1677470,Bactericidal activity against Chlamydia trachomatis serovar J infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.5
63064,,,5214904,[],CHEMBL1677471,Bactericidal activity against Chlamydia trachomatis serovar K infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.5
63065,,,5214905,[],CHEMBL1677472,Antimicrobial activity against Chlamydia trachomatis Ic Cal-8 serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
63066,,,5214906,[],CHEMBL1677473,Antimicrobial activity against Chlamydia trachomatis Bour serovar E infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
63067,,,5214907,[],CHEMBL1677474,Antimicrobial activity against Chlamydia trachomatis 580 serovar H infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
63068,,,5214908,[],CHEMBL1677475,Antimicrobial activity against Chlamydia trachomatis UW-36 serovar J infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.5
63069,,,5214989,[],CHEMBL1677472,Antimicrobial activity against Chlamydia trachomatis Ic Cal-8 serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.5
63070,,,5214990,[],CHEMBL1677473,Antimicrobial activity against Chlamydia trachomatis Bour serovar E infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.5
63071,,,5214991,[],CHEMBL1677474,Antimicrobial activity against Chlamydia trachomatis 580 serovar H infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.5
63072,,,5214992,[],CHEMBL1677475,Antimicrobial activity against Chlamydia trachomatis UW-36 serovar J infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332745,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.5
63073,,,5215130,[],CHEMBL1674201,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,17.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,17.9
63074,,,5215140,[],CHEMBL1674202,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,8.0
63075,,,5215150,[],CHEMBL1674203,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,21.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,21.7
63076,,,5215159,[],CHEMBL1674204,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,73.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,73.9
63077,,,5215169,[],CHEMBL1674205,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
63078,,,5215175,[],CHEMBL1674206,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,98.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,98.5
63079,,,5215181,[],CHEMBL1674207,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,1.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,1.5
63080,,,5215188,[],CHEMBL1674208,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
63081,,,5215194,[],CHEMBL1674209,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,99.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,99.3
63082,,,5215200,[],CHEMBL1674210,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,0.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.7
63083,,,5215207,[],CHEMBL1674211,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.5
63084,,,5215214,[],CHEMBL1674212,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,100.0
63085,,,5215219,[],CHEMBL1674213,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,0.0
63086,,,5215226,[],CHEMBL1674214,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.5
63087,,,5215233,[],CHEMBL1674215,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,100.0
63088,,,5215238,[],CHEMBL1674216,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,0.0
63089,,,5215242,[],CHEMBL1674217,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,100.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,100.0
63090,,,5215252,[],CHEMBL1674218,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,0.5
63091,,,5215256,[],CHEMBL1674219,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,0.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,0.0
63092,,,5215260,[],CHEMBL1674220,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,97.6,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,97.6
63093,,,5215270,[],CHEMBL1674221,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63094,,,5215275,[],CHEMBL1674222,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,2.4,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,2.4
63095,,,5215282,[],CHEMBL1674223,Antibacterial activity against penicillin-susceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63096,,,5215289,[],CHEMBL1674224,Antibacterial activity against penicillin-susceptible Streptococcus viridans assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,100.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,Activity,%,UO_0000187,,100.0
63097,,,5215295,[],CHEMBL1674225,Antibacterial activity against penicillin-susceptible Streptococcus viridans assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,0.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,Activity,%,UO_0000187,,0.0
63098,,,5215304,[],CHEMBL1674226,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63099,,,5215311,[],CHEMBL1674227,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,92.9,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,Activity,%,UO_0000187,,92.9
63100,,,5215318,[],CHEMBL1674228,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,7.1,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,Activity,%,UO_0000187,,7.1
63101,,,5215327,[],CHEMBL1674229,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63102,,,5215334,[],CHEMBL1674230,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,59.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,59.2
63103,,,5215340,[],CHEMBL1674231,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,40.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,40.8
63104,,,5215350,[],CHEMBL1674232,Antibacterial activity against vancomycin-resistant Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC50,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,16.0
63105,,,5215357,[],CHEMBL1674233,Antibacterial activity against vancomycin-resistant Enterococcus faecalis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,4.0
63106,,,5215363,[],CHEMBL1674234,Antibacterial activity against vancomycin-resistant Enterococcus faecalis assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,96.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,96.0
63107,,,5215373,[],CHEMBL1674235,Antibacterial activity against vancomycin-resistant Enterococcus faecium by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC50,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,16.0
63108,,,5215380,[],CHEMBL1674236,Antibacterial activity against vancomycin-resistant Enterococcus faecium assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,0.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,0.0
63109,,,5215386,[],CHEMBL1674237,Antibacterial activity against vancomycin-resistant Enterococcus faecium assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,100.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,100.0
63110,,,5215394,[],CHEMBL1674989,Antibacterial activity against ceftazidime-susceptible Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,MIC50,ug ml-1,UO_0000274,,0.06
63111,,,5215402,[],CHEMBL1674990,Antibacterial activity against ceftazidime-susceptible Enterobacteriaceae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,89.6,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,Activity,%,UO_0000187,,89.6
63112,,,5215410,[],CHEMBL1674991,Antibacterial activity against ceftazidime-susceptible Enterobacteriaceae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,9.4,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,Activity,%,UO_0000187,,9.4
63113,,,5215419,[],CHEMBL1674992,Antibacterial activity against ceftazidime-nonsusceptible Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,MIC50,ug ml-1,UO_0000274,,8.0
63114,,,5215427,[],CHEMBL1674993,Antibacterial activity against ceftazidime-nonsusceptible Enterobacteriaceae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,41.8,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,Activity,%,UO_0000187,,41.8
63115,,,5215435,[],CHEMBL1674994,Antibacterial activity against ceftazidime-nonsusceptible Enterobacteriaceae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,51.4,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,Activity,%,UO_0000187,,51.4
63116,,,5215444,[],CHEMBL1674995,Antibacterial activity against ceftazidime-susceptible Citrobacter freundii by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,,MIC50,ug.mL-1,,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC50,ug ml-1,UO_0000274,,0.03
63117,,,5215452,[],CHEMBL1674996,Antibacterial activity against ceftazidime-susceptible Citrobacter freundii assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,98.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,Activity,%,UO_0000187,,98.0
63118,,,5215460,[],CHEMBL1674997,Antibacterial activity against ceftazidime-susceptible Citrobacter freundii assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,0.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,Activity,%,UO_0000187,,0.0
63119,,,5215469,[],CHEMBL1674998,Antibacterial activity against ceftazidime-nonsusceptible Citrobacter freundii by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC50,ug ml-1,UO_0000274,,0.25
63120,,,5216501,[],CHEMBL1674999,Antibacterial activity against ceftazidime-nonsusceptible Citrobacter freundii assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,72.7,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,Activity,%,UO_0000187,,72.7
63121,,,5216509,[],CHEMBL1675000,Antibacterial activity against ceftazidime-nonsusceptible Citrobacter freundii assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,24.2,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,Activity,%,UO_0000187,,24.2
63122,,,5216518,[],CHEMBL1675001,Antibacterial activity against ceftazidime-susceptible Enterobacter cloacae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,,MIC50,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC50,ug ml-1,UO_0000274,,0.03
63123,,,5216526,[],CHEMBL1675002,Antibacterial activity against ceftazidime-susceptible Enterobacter cloacae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,94.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,94.0
63124,,,5216534,[],CHEMBL1675003,Antibacterial activity against ceftazidime-susceptible Enterobacter cloacae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,2.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,2.0
63125,,,5216543,[],CHEMBL1675004,Antibacterial activity against ceftazidime-nonsusceptible Enterobacter cloacae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC50,ug ml-1,UO_0000274,,0.12
63126,,,5216551,[],CHEMBL1675005,Antibacterial activity against ceftazidime-nonsusceptible Enterobacter cloacae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,62.9,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,62.9
63127,,,5216559,[],CHEMBL1675006,Antibacterial activity against ceftazidime-nonsusceptible Enterobacter cloacae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,25.7,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,25.7
63128,,,5216568,[],CHEMBL1675007,Antibacterial activity against ceftazidime-susceptible Escherichia coli by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,,MIC50,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,0.03
63129,,,5216576,[],CHEMBL1675008,Antibacterial activity against ceftazidime-susceptible Escherichia coli assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,86.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,86.4
63130,,,5216584,[],CHEMBL1675009,Antibacterial activity against ceftazidime-susceptible Escherichia coli assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,13.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,13.6
63131,,,5216593,[],CHEMBL1675143,Antibacterial activity against ceftazidime-nonsusceptible Escherichia coli by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC50,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,16.0
63132,,,5216601,[],CHEMBL1675144,Antibacterial activity against ceftazidime-nonsusceptible Escherichia coli assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,14.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,14.3
63133,,,5216609,[],CHEMBL1675145,Antibacterial activity against ceftazidime-nonsusceptible Escherichia coli assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,85.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,85.7
63134,,,5216618,[],CHEMBL1675146,Antibacterial activity against ceftazidime-susceptible Klebsiella pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,0.06
63135,,,5216626,[],CHEMBL1675147,Antibacterial activity against ceftazidime-susceptible Klebsiella pneumoniae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,98.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,98.1
63136,,,5216634,[],CHEMBL1675148,Antibacterial activity against ceftazidime-susceptible Klebsiella pneumoniae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,1.4,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,1.4
63137,,,5216643,[],CHEMBL1675149,Antibacterial activity against ceftazidime-nonsusceptible Klebsiella pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,8.0
63138,,,5216651,[],CHEMBL1675150,Antibacterial activity against ceftazidime-nonsusceptible Klebsiella pneumoniae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,37.9,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,37.9
63139,,,5216659,[],CHEMBL1675151,Antibacterial activity against ceftazidime-nonsusceptible Klebsiella pneumoniae assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,54.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,54.5
63140,,,5216668,[],CHEMBL1675152,Antibacterial activity against ceftazidime-susceptible Morganella morganii by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,,MIC50,ug.mL-1,,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC50,ug ml-1,UO_0000274,,0.03
63141,,,5216676,[],CHEMBL1675153,Antibacterial activity against ceftazidime-susceptible Morganella morganii assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,76.5,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,Activity,%,UO_0000187,,76.5
63142,,,5216684,[],CHEMBL1675154,Antibacterial activity against ceftazidime-susceptible Morganella morganii assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,20.6,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,Activity,%,UO_0000187,,20.6
63143,,,5216693,[],CHEMBL1675155,Antibacterial activity against ceftazidime-susceptible Proteus mirabilis by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC50,ug ml-1,UO_0000274,,0.06
63144,,,5216701,[],CHEMBL1675156,Antibacterial activity against ceftazidime-susceptible Proteus mirabilis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,75.9,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,75.9
63145,,,5216709,[],CHEMBL1675157,Antibacterial activity against ceftazidime-susceptible Proteus mirabilis assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,20.7,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,20.7
63146,,,5216718,[],CHEMBL1675158,Antibacterial activity against ceftazidime-susceptible Serratia marcescens by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC50,ug ml-1,UO_0000274,,0.12
63147,,,5216726,[],CHEMBL1675159,Antibacterial activity against ceftazidime-susceptible Serratia marcescens assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,98.3,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Activity,%,UO_0000187,,98.3
63148,,,5216734,[],CHEMBL1675160,Antibacterial activity against ceftazidime-susceptible Serratia marcescens assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,1.7,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Activity,%,UO_0000187,,1.7
63149,,,5216743,[],CHEMBL1675161,Antibacterial activity against multidrug-resistant Acinetobacter by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC50,ug ml-1,UO_0000274,,16.0
63150,,,5216751,[],CHEMBL1675162,Antibacterial activity against multidrug-resistant Acinetobacter assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,6.3,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,Activity,%,UO_0000187,,6.3
63151,,,5216758,[],CHEMBL1675163,Antibacterial activity against multidrug-resistant Acinetobacter assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,87.5,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,Activity,%,UO_0000187,,87.5
63152,,,5216766,[],CHEMBL1675164,Antibacterial activity against imipenem-susceptible Acinetobacter by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC50,ug ml-1,UO_0000274,,0.5
63153,,,5216774,[],CHEMBL1675165,Antibacterial activity against imipenem-susceptible Acinetobacter assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,51.1,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,Activity,%,UO_0000187,,51.1
63154,,,5216781,[],CHEMBL1675166,Antibacterial activity against imipenem-susceptible Acinetobacter assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,36.2,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,Activity,%,UO_0000187,,36.2
63155,,,5216789,[],CHEMBL1675167,Antibacterial activity against beta lactamase-negative Haemophilus influenzae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,0.015
63156,,,5216797,[],CHEMBL1675168,Antibacterial activity against beta lactamase-negative Haemophilus influenzae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,100.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Activity,%,UO_0000187,,100.0
63157,,,5216807,[],CHEMBL1675170,Antibacterial activity against beta lactamase-positive Haemophilus influenzae by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,0.015
63158,,,5216815,[],CHEMBL1675171,Antibacterial activity against beta lactamase-positive Haemophilus influenzae assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,100.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Activity,%,UO_0000187,,100.0
63159,,,5216827,[],CHEMBL1675173,Antibacterial activity against beta lactamase-positive Moraxella catarrhalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,,MIC50,ug.mL-1,,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC50,ug ml-1,UO_0000274,,0.03
63160,,,5216834,[],CHEMBL1675174,Antibacterial activity against beta lactamase-positive Moraxella catarrhalis assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,100.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Activity,%,UO_0000187,,100.0
63161,,,5216841,[],CHEMBL1675176,Antibacterial activity against Pasteurella multocida by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,,MIC50,ug.mL-1,,0.015,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC50,ug ml-1,UO_0000274,,0.015
63162,,,5217882,[],CHEMBL1675177,Antibacterial activity against Pasteurella multocida assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,95.5,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,Activity,%,UO_0000187,,95.5
63163,,,5217888,[],CHEMBL1675179,Antibacterial activity against ceftazidime-susceptible Providencia sp. by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612538,Providencia sp.,Providencia sp.,589.0,,,MIC50,ug ml-1,UO_0000274,,0.25
63164,,,5217896,[],CHEMBL1675180,Antibacterial activity against ceftazidime-susceptible Providencia sp. assessed as susceptible isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,66.7,CHEMBL612538,Providencia sp.,Providencia sp.,589.0,,,Activity,%,UO_0000187,,66.7
63165,,,5217904,[],CHEMBL1675181,Antibacterial activity against ceftazidime-susceptible Providencia sp. assessed as resistant isolates by CLSI M7-A7 broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331822,=,1,0,=,,Activity,%,,25.9,CHEMBL612538,Providencia sp.,Providencia sp.,589.0,,,Activity,%,UO_0000187,,25.9
63166,,,5217915,[],CHEMBL1674079,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63167,,,5217926,[],CHEMBL1674079,Antibacterial activity against methicillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
63168,,,5217937,[],CHEMBL1674082,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63169,,,5217948,[],CHEMBL1674082,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
63170,,,5217959,[],CHEMBL1674199,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
63171,,,5217970,[],CHEMBL1674199,Antibacterial activity against coagulase-negative and oxacillin-susceptible Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
63172,,,5217981,[],CHEMBL1674202,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63173,,,5217992,[],CHEMBL1674202,Antibacterial activity against coagulase-negative and oxacillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
63174,,,5218003,[],CHEMBL1674205,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63175,,,5218012,[],CHEMBL1674205,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
63176,,,5218021,[],CHEMBL1674208,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63177,,,5218030,[],CHEMBL1674208,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
63178,,,5218039,[],CHEMBL1674211,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63179,,,5218049,[],CHEMBL1674211,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.03
63180,,,5218059,[],CHEMBL1674214,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63181,,,5218069,[],CHEMBL1674214,Antibacterial activity against erythromycin-nonsusceptible Streptococcus pyogenes by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
63182,,,5218079,[],CHEMBL1674218,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63183,,,5218089,[],CHEMBL1674218,Antibacterial activity against erythromycin-susceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.12
63184,,,5218099,[],CHEMBL1674221,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63185,,,5218109,[],CHEMBL1674221,Antibacterial activity against erythromycin-nonsusceptible Streptococcus agalactiae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.5
63186,,,5218119,[],CHEMBL1674223,Antibacterial activity against penicillin-susceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63187,,,5218129,[],CHEMBL1674223,Antibacterial activity against penicillin-susceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,0.015
63188,,,5218139,[],CHEMBL1674226,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC90,ug ml-1,UO_0000274,,2.0
63189,,,5218149,[],CHEMBL1674226,Antibacterial activity against penicillin-nonsusceptible Streptococcus viridans by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC,ug.mL-1,,0.12,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,0.12
63190,,,5218159,[],CHEMBL1674229,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63191,,,5218170,[],CHEMBL1674229,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
63192,,,5218181,[],CHEMBL1674232,Antibacterial activity against vancomycin-resistant Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63193,,,5218192,[],CHEMBL1674232,Antibacterial activity against vancomycin-resistant Enterococcus faecalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
63194,,,5218203,[],CHEMBL1674235,Antibacterial activity against vancomycin-resistant Enterococcus faecium by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63195,,,5218214,[],CHEMBL1674235,Antibacterial activity against vancomycin-resistant Enterococcus faecium by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,16.0
63196,,,5218863,[],CHEMBL1678578,Antimicrobial activity against Staphylococcus aureus USA300 isolate harboring pSK41 plasmid assessed resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671712,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332354,=,1,0,=,,Activity,%,,45.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,45.0
63197,,,5219281,[],CHEMBL1674989,Antibacterial activity against ceftazidime-susceptible Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,MIC90,ug ml-1,UO_0000274,,4.0
63198,,,5219290,[],CHEMBL1674989,Antibacterial activity against ceftazidime-susceptible Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,MIC,ug ml-1,UO_0000274,,0.03
63199,,,5219299,[],CHEMBL1674992,Antibacterial activity against ceftazidime-nonsusceptible Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63200,,,5219308,[],CHEMBL1674992,Antibacterial activity against ceftazidime-nonsusceptible Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,MIC,ug ml-1,UO_0000274,,0.03
63201,,,5219317,[],CHEMBL1674995,Antibacterial activity against ceftazidime-susceptible Citrobacter freundii by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63202,,,5219326,[],CHEMBL1674995,Antibacterial activity against ceftazidime-susceptible Citrobacter freundii by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.03
63203,,,5219335,[],CHEMBL1674998,Antibacterial activity against ceftazidime-nonsusceptible Citrobacter freundii by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63204,,,5219344,[],CHEMBL1674998,Antibacterial activity against ceftazidime-nonsusceptible Citrobacter freundii by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.03
63205,,,5219353,[],CHEMBL1675001,Antibacterial activity against ceftazidime-susceptible Enterobacter cloacae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC90,ug ml-1,UO_0000274,,0.5
63206,,,5219362,[],CHEMBL1675001,Antibacterial activity against ceftazidime-susceptible Enterobacter cloacae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.03
63207,,,5219371,[],CHEMBL1675004,Antibacterial activity against ceftazidime-nonsusceptible Enterobacter cloacae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63208,,,5219380,[],CHEMBL1675004,Antibacterial activity against ceftazidime-nonsusceptible Enterobacter cloacae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.03
63209,,,5219389,[],CHEMBL1675007,Antibacterial activity against ceftazidime-susceptible Escherichia coli by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63210,,,5219398,[],CHEMBL1675007,Antibacterial activity against ceftazidime-susceptible Escherichia coli by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
63211,,,5219407,[],CHEMBL1675143,Antibacterial activity against ceftazidime-nonsusceptible Escherichia coli by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63212,,,5219416,[],CHEMBL1675143,Antibacterial activity against ceftazidime-nonsusceptible Escherichia coli by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
63213,,,5219425,[],CHEMBL1675146,Antibacterial activity against ceftazidime-susceptible Klebsiella pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,0.25
63214,,,5219434,[],CHEMBL1675146,Antibacterial activity against ceftazidime-susceptible Klebsiella pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
63215,,,5219443,[],CHEMBL1675149,Antibacterial activity against ceftazidime-nonsusceptible Klebsiella pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63216,,,5219452,[],CHEMBL1675149,Antibacterial activity against ceftazidime-nonsusceptible Klebsiella pneumoniae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
63217,,,5219461,[],CHEMBL1675152,Antibacterial activity against ceftazidime-susceptible Morganella morganii by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC90,ug ml-1,UO_0000274,,8.0
63218,,,5219470,[],CHEMBL1675152,Antibacterial activity against ceftazidime-susceptible Morganella morganii by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.03
63219,,,5219479,[],CHEMBL1675155,Antibacterial activity against ceftazidime-susceptible Proteus mirabilis by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63220,,,5219488,[],CHEMBL1675155,Antibacterial activity against ceftazidime-susceptible Proteus mirabilis by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.03
63221,,,5219497,[],CHEMBL1675158,Antibacterial activity against ceftazidime-susceptible Serratia marcescens by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63222,,,5219506,[],CHEMBL1675158,Antibacterial activity against ceftazidime-susceptible Serratia marcescens by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.03
63223,,,5219515,[],CHEMBL1675161,Antibacterial activity against multidrug-resistant Acinetobacter by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63224,,,5219524,[],CHEMBL1675161,Antibacterial activity against multidrug-resistant Acinetobacter by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC,ug ml-1,UO_0000274,,2.0
63225,,,5219533,[],CHEMBL1675164,Antibacterial activity against imipenem-susceptible Acinetobacter by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63226,,,5219542,[],CHEMBL1675164,Antibacterial activity against imipenem-susceptible Acinetobacter by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL614424,Acinetobacter,Acinetobacter,469.0,,,MIC,ug ml-1,UO_0000274,,0.03
63227,,,5219551,[],CHEMBL1675167,Antibacterial activity against beta lactamase-negative Haemophilus influenzae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.03
63228,,,5219560,[],CHEMBL1675167,Antibacterial activity against beta lactamase-negative Haemophilus influenzae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,,MIC,ug.mL-1,,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.004
63229,,,5219569,[],CHEMBL1675170,Antibacterial activity against beta lactamase-positive Haemophilus influenzae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.03
63230,,,5219578,[],CHEMBL1675170,Antibacterial activity against beta lactamase-positive Haemophilus influenzae by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,,MIC,ug.mL-1,,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.004
63231,,,5219588,[],CHEMBL1675173,Antibacterial activity against beta lactamase-positive Moraxella catarrhalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,,MIC90,ug.mL-1,,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,0.03
63232,,,5219597,[],CHEMBL1675173,Antibacterial activity against beta lactamase-positive Moraxella catarrhalis by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.03
63233,,,5220663,[],CHEMBL1675176,Antibacterial activity against Pasteurella multocida by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC90,ug ml-1,UO_0000274,,0.03
63234,,,5220671,[],CHEMBL1675176,Antibacterial activity against Pasteurella multocida by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,,MIC,ug.mL-1,,0.015,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC,ug ml-1,UO_0000274,,0.015
63235,,,5220678,[],CHEMBL1675179,Antibacterial activity against ceftazidime-susceptible Providencia sp. by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL612538,Providencia sp.,Providencia sp.,589.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63236,,,5220687,[],CHEMBL1675179,Antibacterial activity against ceftazidime-susceptible Providencia sp. by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671626,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331822,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL612538,Providencia sp.,Providencia sp.,589.0,,,MIC,ug ml-1,UO_0000274,,0.03
63237,,,5220698,[],CHEMBL1675182,Antibacterial activity against Bacteroides fragilis by by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,1.0
63238,,,5220712,[],CHEMBL1675185,Antibacterial activity against beta-lactamase producing Bacteroides thetaiotaomicron by by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,2.0
63239,,,5220726,[],CHEMBL1675182,Antibacterial activity against Bacteroides fragilis by by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC50,ug ml-1,UO_0000274,,2.0
63240,,,5220740,[],CHEMBL1675185,Antibacterial activity against beta-lactamase producing Bacteroides thetaiotaomicron by by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC50,ug ml-1,UO_0000274,,4.0
63241,,,5220754,[],CHEMBL1675182,Antibacterial activity against Bacteroides fragilis by by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,ug ml-1,UO_0000274,,8.0
63242,,,5220768,[],CHEMBL1675185,Antibacterial activity against beta-lactamase producing Bacteroides thetaiotaomicron by by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC90,ug ml-1,UO_0000274,,8.0
63243,,,5220834,[],CHEMBL1673478,Antibacterial activity against beta-lactamase producing Bacteroides vulgatus by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC,ug ml-1,UO_0000274,,0.5
63244,,,5220846,[],CHEMBL1673478,Antibacterial activity against beta-lactamase producing Bacteroides vulgatus by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC50,ug ml-1,UO_0000274,,2.0
63245,,,5220858,[],CHEMBL1673478,Antibacterial activity against beta-lactamase producing Bacteroides vulgatus by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC90,ug ml-1,UO_0000274,,8.0
63246,,,5220902,[],CHEMBL1673762,Antibacterial activity against beta-lactamase producing Bacteroides uniformis by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,,MIC,ug ml-1,UO_0000274,,0.5
63247,,,5220914,[],CHEMBL1673762,Antibacterial activity against beta-lactamase producing Bacteroides uniformis by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,,MIC50,ug ml-1,UO_0000274,,2.0
63248,,,5220926,[],CHEMBL1673762,Antibacterial activity against beta-lactamase producing Bacteroides uniformis by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,,MIC90,ug ml-1,UO_0000274,,8.0
63249,,,5220970,[],CHEMBL1673771,Antibacterial activity against beta-lactamase producing Bacteroides caccae by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,,MIC,ug ml-1,UO_0000274,,0.5
63250,,,5220982,[],CHEMBL1673771,Antibacterial activity against beta-lactamase producing Bacteroides caccae by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,,MIC50,ug ml-1,UO_0000274,,2.0
63251,,,5220994,[],CHEMBL1673771,Antibacterial activity against beta-lactamase producing Bacteroides caccae by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,,MIC90,ug ml-1,UO_0000274,,8.0
63252,,,5222083,[],CHEMBL1673780,Antibacterial activity against Fusobacterium varium by by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,,MIC,ug ml-1,UO_0000274,,0.12
63253,,,5222095,[],CHEMBL1673781,Antibacterial activity against Fusobacterium nucleatum by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,,MIC,ug ml-1,UO_0000274,,0.12
63254,,,5222107,[],CHEMBL1673782,Antibacterial activity against Fusobacterium mortiferum by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,,MIC,ug ml-1,UO_0000274,,0.12
63255,,,5222119,[],CHEMBL1673783,Antibacterial activity against Fusobacterium necrophorum by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,,MIC,ug ml-1,UO_0000274,,0.12
63256,,,5222131,[],CHEMBL1673780,Antibacterial activity against Fusobacterium varium by by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,,MIC50,ug ml-1,UO_0000274,,2.0
63257,,,5222143,[],CHEMBL1673781,Antibacterial activity against Fusobacterium nucleatum by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,,MIC50,ug ml-1,UO_0000274,,2.0
63258,,,5222155,[],CHEMBL1673782,Antibacterial activity against Fusobacterium mortiferum by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,,MIC50,ug ml-1,UO_0000274,,2.0
63259,,,5222167,[],CHEMBL1673783,Antibacterial activity against Fusobacterium necrophorum by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,,MIC50,ug ml-1,UO_0000274,,2.0
63260,,,5222179,[],CHEMBL1673780,Antibacterial activity against Fusobacterium varium by by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,,MIC90,ug ml-1,UO_0000274,,4.0
63261,,,5222191,[],CHEMBL1673781,Antibacterial activity against Fusobacterium nucleatum by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,,MIC90,ug ml-1,UO_0000274,,4.0
63262,,,5222203,[],CHEMBL1673782,Antibacterial activity against Fusobacterium mortiferum by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,,MIC90,ug ml-1,UO_0000274,,4.0
63263,,,5222215,[],CHEMBL1673783,Antibacterial activity against Fusobacterium necrophorum by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,,MIC90,ug ml-1,UO_0000274,,4.0
63264,,,5222355,[],CHEMBL1674570,Antibacterial activity against Prevotella buccae by by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,,MIC,ug ml-1,UO_0000274,,0.25
63265,,,5222367,[],CHEMBL1674571,Antibacterial activity against Prevotella bivia by by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,,MIC,ug ml-1,UO_0000274,,0.25
63266,,,5222379,[],CHEMBL1674572,Antibacterial activity against Prevotella intermedia by by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,,MIC,ug ml-1,UO_0000274,,0.25
63267,,,5222391,[],CHEMBL1674573,Antibacterial activity against Prevotella melaninogenica by by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC,ug ml-1,UO_0000274,,0.25
63268,,,5222466,[],CHEMBL1674471,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Corvallis isolate s2017 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,1.0
63269,,,5222467,[],CHEMBL1674470,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Stanley isolate s2018 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,1.0
63270,,,5222468,[],CHEMBL1674469,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Corvallis isolate s2052 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
63271,,,5222469,[],CHEMBL1674468,Antimicrobial activity against qnrA-positive Salmonella enterica serovar Mbandaka isolate s2093 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,1.0
63272,,,5222470,[],CHEMBL1674467,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Montevideo isolate s2209 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,1.0
63273,,,5222471,[],CHEMBL1674466,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Virginia isolate s2219 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,1.0
63274,,,5222472,[],CHEMBL1674465,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Typhimurium isolate s2425 harboring wild type ParC gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,1.0
63275,,,5222473,[],CHEMBL1674464,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Typhimurium isolate s2705 harboring wild type ParC gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,1.0
63276,,,5222474,[],CHEMBL1674463,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Braenderup isolate s2856 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,1.0
63277,,,5222475,[],CHEMBL1674462,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Montevideo isolate s2944 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,1.0
63278,,,5222476,[],CHEMBL1674461,Antimicrobial activity against Salmonella enterica serovar Stanley isolate s2043 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.06
63279,,,5222477,[],CHEMBL1674340,Antimicrobial activity against Salmonella enterica serovar Corvallis isolate s2064 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.06
63280,,,5222478,[],CHEMBL1674339,Antimicrobial activity against Salmonella enterica serovar Mbandaka isolate s2159 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.06
63281,,,5222479,[],CHEMBL1674338,Antimicrobial activity against Salmonella enterica serovar Montevideo isolate s2317 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332014,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.06
63282,,Not Determined,5222480,[],CHEMBL1674337,Antimicrobial activity against Salmonella enterica serovar Typhimurium isolate s2878 harboring wild type ParC gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332014,,1,0,,,MIC,,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,,,,
63283,,Not Determined,5222481,[],CHEMBL1674336,Antimicrobial activity against Salmonella enterica serovar Braenderup isolate s2906 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332014,,1,0,,,MIC,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,,,,
63284,,Not Determined,5222482,[],CHEMBL1674335,Antimicrobial activity against Salmonella enterica serovar Typhimurium isolate SL1344 harboring wild type ParC gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332014,,1,0,,,MIC,,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,,,,
63285,,,5223455,[],CHEMBL1674570,Antibacterial activity against Prevotella buccae by by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63286,,,5223467,[],CHEMBL1674571,Antibacterial activity against Prevotella bivia by by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63287,,,5223479,[],CHEMBL1674572,Antibacterial activity against Prevotella intermedia by by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63288,,,5223491,[],CHEMBL1674573,Antibacterial activity against Prevotella melaninogenica by by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63289,,,5223503,[],CHEMBL1674570,Antibacterial activity against Prevotella buccae by by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63290,,,5223515,[],CHEMBL1674571,Antibacterial activity against Prevotella bivia by by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63291,,,5223527,[],CHEMBL1674572,Antibacterial activity against Prevotella intermedia by by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63292,,,5223539,[],CHEMBL1674573,Antibacterial activity against Prevotella melaninogenica by by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63293,,,5223679,[],CHEMBL1674730,Antibacterial activity against Veillonella parvula by by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612244,Veillonella parvula,Veillonella parvula,29466.0,,,MIC,ug ml-1,UO_0000274,,0.06
63294,,,5223693,[],CHEMBL1674733,Antibacterial activity against beta-lactamase producing Clostridium perfringens by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.25
63295,,,5223705,[],CHEMBL1674734,Antibacterial activity against beta-lactamase producing Clostridium paraputrificum by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,,MIC,ug ml-1,UO_0000274,,0.25
63296,,,5223717,[],CHEMBL1674735,Antibacterial activity against beta-lactamase producing Clostridium septicum by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,,MIC,ug ml-1,UO_0000274,,0.25
63297,,,5223729,[],CHEMBL1674736,Antibacterial activity against beta-lactamase producing Clostridium tertium by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,,MIC,ug ml-1,UO_0000274,,0.25
63298,,,5223749,[],CHEMBL1674733,Antibacterial activity against beta-lactamase producing Clostridium perfringens by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC50,ug ml-1,UO_0000274,,0.5
63299,,,5223761,[],CHEMBL1674734,Antibacterial activity against beta-lactamase producing Clostridium paraputrificum by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,,MIC50,ug ml-1,UO_0000274,,0.5
63300,,,5223773,[],CHEMBL1674735,Antibacterial activity against beta-lactamase producing Clostridium septicum by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,,MIC50,ug ml-1,UO_0000274,,0.5
63301,,,5223785,[],CHEMBL1674736,Antibacterial activity against beta-lactamase producing Clostridium tertium by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,,MIC50,ug ml-1,UO_0000274,,0.5
63302,,,5224860,[],CHEMBL1674733,Antibacterial activity against beta-lactamase producing Clostridium perfringens by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC90,ug ml-1,UO_0000274,,4.0
63303,,,5224872,[],CHEMBL1674734,Antibacterial activity against beta-lactamase producing Clostridium paraputrificum by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,,MIC90,ug ml-1,UO_0000274,,4.0
63304,,,5224884,[],CHEMBL1674735,Antibacterial activity against beta-lactamase producing Clostridium septicum by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,,MIC90,ug ml-1,UO_0000274,,4.0
63305,,,5224896,[],CHEMBL1674736,Antibacterial activity against beta-lactamase producing Clostridium tertium by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,,MIC90,ug ml-1,UO_0000274,,4.0
63306,,,5225012,[],CHEMBL1675645,Antibacterial activity against beta-lactamase producing Peptostreptococcus anaerobius by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,,MIC,ug.mL-1,,0.03,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC,ug ml-1,UO_0000274,,0.03
63307,,,5225026,[],CHEMBL1675645,Antibacterial activity against beta-lactamase producing Peptostreptococcus anaerobius by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC50,ug ml-1,UO_0000274,,0.5
63308,,,5225040,[],CHEMBL1675645,Antibacterial activity against beta-lactamase producing Peptostreptococcus anaerobius by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC90,ug ml-1,UO_0000274,,32.0
63309,,,5225078,[],CHEMBL1675654,Antibacterial activity against beta-lactamase producing Micromonas micros by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,,MIC,ug.mL-1,,0.03,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,,MIC,ug ml-1,UO_0000274,,0.03
63310,,,5225090,[],CHEMBL1675654,Antibacterial activity against beta-lactamase producing Micromonas micros by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,,MIC50,ug ml-1,UO_0000274,,0.5
63311,,,5225102,[],CHEMBL1675654,Antibacterial activity against beta-lactamase producing Micromonas micros by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,,MIC90,ug ml-1,UO_0000274,,32.0
63312,,,5225144,[],CHEMBL1675663,Antibacterial activity against beta-lactamase producing Peptoniphilus asaccharolyticus by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,,MIC,ug.mL-1,,0.03,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC,ug ml-1,UO_0000274,,0.03
63313,,,5225156,[],CHEMBL1675663,Antibacterial activity against beta-lactamase producing Peptoniphilus asaccharolyticus by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC50,ug ml-1,UO_0000274,,0.5
63314,,,5225168,[],CHEMBL1675663,Antibacterial activity against beta-lactamase producing Peptoniphilus asaccharolyticus by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC90,ug ml-1,UO_0000274,,32.0
63315,,,5225345,[],CHEMBL1680543,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,90.3,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,90.3
63316,,,5225353,[],CHEMBL1679664,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332069,>=,1,1,>=,,MIC50,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,32.0
63317,,,5225358,[],CHEMBL1679789,Antibacterial activity against Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332069,>=,1,1,>=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
63318,,,5225365,[],CHEMBL1679794,Antibacterial activity against Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332069,<=,1,1,<=,,MIC90,ug.mL-1,,0.06,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,MIC90,ug ml-1,UO_0000274,,0.06
63319,,,5225380,[],CHEMBL1679806,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.5
63320,,,5225384,[],CHEMBL1679807,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,13.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,13.4
63321,,,5225388,[],CHEMBL1679808,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,81.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,81.8
63322,,,5225392,[],CHEMBL1679809,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,88.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,88.8
63323,,,5225395,[],CHEMBL1679810,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,91.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,91.4
63324,,,5225402,[],CHEMBL1679812,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,92.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,92.0
63325,,,5225405,[],CHEMBL1679813,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,93.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,93.6
63326,,,5225411,[],CHEMBL1679815,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
63327,,,5225416,[],CHEMBL1679820,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.8
63328,,,5225420,[],CHEMBL1679821,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,8.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,8.7
63329,,,5225425,[],CHEMBL1679961,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,9.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,9.4
63330,,,5225432,[],CHEMBL1679964,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,22.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,22.8
63331,,,5225436,[],CHEMBL1679965,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,24.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,24.4
63332,,,5225438,[],CHEMBL1679966,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
63333,,,5225473,[],CHEMBL1680856,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,4.0
63334,,,5225477,[],CHEMBL1680857,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,24.0
63335,,,5225481,[],CHEMBL1680859,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,32.0
63336,,,5225485,[],CHEMBL1680862,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,96.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,96.0
63337,,,5225487,[],CHEMBL1680863,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
63338,,,5225492,[],CHEMBL1680967,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,3.0
63339,,,5225500,[],CHEMBL1680972,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,4.0
63340,,,5225504,[],CHEMBL1680973,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,5.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,5.1
63341,,,5225506,[],CHEMBL1680974,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
63342,,,5225515,[],CHEMBL1680979,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,11.6,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,11.6
63343,,,5225519,[],CHEMBL1680980,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,53.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,53.5
63344,,,5225526,[],CHEMBL1679336,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,55.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,55.8
63345,,,5225530,[],CHEMBL1679337,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,62.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,62.8
63346,,,5225533,[],CHEMBL1679338,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,76.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,76.7
63347,,,5225536,[],CHEMBL1679339,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,88.4,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,88.4
63348,,,5225538,[],CHEMBL1679340,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,100.0
63349,,,5225543,[],CHEMBL1679345,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,11.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,11.1
63350,,,5225547,[],CHEMBL1679347,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,33.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,33.3
63351,,,5225549,[],CHEMBL1679348,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,100.0
63352,,,5225555,[],CHEMBL1679352,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.5
63353,,,5226185,[],CHEMBL1674838,Antimicrobial activity against Escherichia coli isolate GZ3 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
63354,,,5226186,[],CHEMBL1674839,Antimicrobial activity against Escherichia coli isolate GZ4 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
63355,,,5226187,[],CHEMBL1674840,Antimicrobial activity against Escherichia coli isolate GZ5 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
63356,,,5226188,[],CHEMBL1674841,Antimicrobial activity against Escherichia coli isolate GZ6 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
63357,,,5226189,[],CHEMBL1674842,Antimicrobial activity against Escherichia coli isolate GZ8 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
63358,,,5226190,[],CHEMBL1674843,Antimicrobial activity against Escherichia coli isolate GZ9 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
63359,,,5226191,[],CHEMBL1674844,Antimicrobial activity against Escherichia coli isolate GZ11 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
63360,,,5226192,[],CHEMBL1674845,Antimicrobial activity against Escherichia coli isolate GZ12 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
63361,,,5226193,[],CHEMBL1674846,Antimicrobial activity against Escherichia coli isolate GZ13 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
63362,,,5226194,[],CHEMBL1674847,Antimicrobial activity against Escherichia coli isolate GZ14 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
63363,,,5226195,[],CHEMBL1674848,Antimicrobial activity against Escherichia coli isolate GZ15 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
63364,,,5226196,[],CHEMBL1674849,Antimicrobial activity against Escherichia coli isolate GZ16 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
63365,,,5226197,[],CHEMBL1674850,Antimicrobial activity against Escherichia coli isolate CQ15 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
63366,,,5226198,[],CHEMBL1674851,Antimicrobial activity against Escherichia coli isolate CQ18 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
63367,,,5226199,[],CHEMBL1674852,Antimicrobial activity against Escherichia coli isolate CQ2 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
63368,,,5226200,[],CHEMBL1674853,Antimicrobial activity against Escherichia coli isolate CQ5 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
63369,,,5226201,[],CHEMBL1674854,Antimicrobial activity against Escherichia coli isolate CQ4 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
63370,,,5226202,[],CHEMBL1674855,Antimicrobial activity against Escherichia coli isolate CQ20 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
63371,,,5226203,[],CHEMBL1674856,Antimicrobial activity against Escherichia coli isolate CQ26 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
63372,,,5226204,[],CHEMBL1674857,Antimicrobial activity against Escherichia coli isolate CQ10 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
63373,,,5226205,[],CHEMBL1674972,Antimicrobial activity against Escherichia coli isolate CQ14 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
63374,,,5226206,[],CHEMBL1674973,Antimicrobial activity against Escherichia coli isolate GZ7 transconjugant harboring 16S rRNA methylase RmtB and qepA and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
63375,,,5226207,[],CHEMBL1674974,Antimicrobial activity against Escherichia coli isolate GZ1 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
63376,,,5226208,[],CHEMBL1674975,Antimicrobial activity against Escherichia coli isolate GZ2 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
63377,,,5226209,[],CHEMBL1674976,Antimicrobial activity against Escherichia coli isolate CQ22 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
63378,,,5226210,[],CHEMBL1674977,Antimicrobial activity against Escherichia coli isolate CQ13 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
63379,,,5226211,[],CHEMBL1674978,"Antimicrobial activity against Escherichia coli isolate CQ6 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
63380,,,5226212,[],CHEMBL1674979,"Antimicrobial activity against Escherichia coli isolate CQ7 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
63381,,,5226213,[],CHEMBL1674980,"Antimicrobial activity against Escherichia coli isolate CQ12 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
63382,,,5226214,[],CHEMBL1674981,"Antimicrobial activity against Escherichia coli isolate CQ16 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
63383,,,5226215,[],CHEMBL1674982,"Antimicrobial activity against Escherichia coli isolate GZ10 transconjugant harboring 16S rRNA methylase RmtB and qepA, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
63384,,,5226216,[],CHEMBL1674983,"Antimicrobial activity against Escherichia coli isolate CQ19 transconjugant harboring 16S rRNA methylase RmtB and qepA, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
63385,,,5226217,[],CHEMBL1674984,Antimicrobial activity against Escherichia coli isolate CQ1 transconjugant harboring 16S rRNA methylase RmtB and qnrB6 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331644,=,1,0,=,,FC,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,1.0
63386,,,5226337,[],CHEMBL1675672,Antibacterial activity against beta-lactamase producing Finegoldia magna by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,>,1,1,>,,MIC,ug.mL-1,,0.03,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,,MIC,ug ml-1,UO_0000274,,0.03
63387,,,5226349,[],CHEMBL1675672,Antibacterial activity against beta-lactamase producing Finegoldia magna by CLSI agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,,MIC50,ug ml-1,UO_0000274,,0.5
63388,,,5226361,[],CHEMBL1675672,Antibacterial activity against beta-lactamase producing Finegoldia magna by CLSI agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331838,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,,MIC90,ug ml-1,UO_0000274,,32.0
63389,,,5226683,[],CHEMBL1679353,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,1.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,1.2
63390,,,5226687,[],CHEMBL1679354,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,10.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,10.2
63391,,,5226690,[],CHEMBL1679355,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,69.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,69.3
63392,,,5226693,[],CHEMBL1679356,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,96.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,96.3
63393,,,5226695,[],CHEMBL1679357,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,99.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,99.4
63394,,,5226700,[],CHEMBL1679511,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,99.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,99.5
63395,,,5226703,[],CHEMBL1679512,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,99.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,99.8
63396,,,5226704,[],CHEMBL1679513,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
63397,,,5226710,[],CHEMBL1679518,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,3.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,3.1
63398,,,5226713,[],CHEMBL1679519,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,53.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,53.1
63399,,,5226715,[],CHEMBL1679520,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,90.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,90.6
63400,,,5226717,[],CHEMBL1679521,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
63401,,,5226725,[],CHEMBL1679527,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,2.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,2.5
63402,,,5226732,[],CHEMBL1679529,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,35.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,35.8
63403,,,5226736,[],CHEMBL1679530,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,67.9,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,67.9
63404,,,5226743,[],CHEMBL1679534,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,100.0
63405,,,5226751,[],CHEMBL1680375,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,10.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,10.5
63406,,,5226755,[],CHEMBL1680376,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,23.7,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,23.7
63407,,,5226758,[],CHEMBL1680377,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,28.9,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,28.9
63408,,,5226767,[],CHEMBL1680380,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,100.0
63409,,,5226774,[],CHEMBL1680385,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,66.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,66.4
63410,,,5226778,[],CHEMBL1680386,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,67.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,67.8
63411,,,5226782,[],CHEMBL1680387,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,70.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,70.0
63412,,,5226786,[],CHEMBL1680388,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,73.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,73.6
63413,,,5226790,[],CHEMBL1680389,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,75.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,75.1
63414,,,5226797,[],CHEMBL1680391,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,75.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,75.6
63415,,,5226800,[],CHEMBL1680392,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,78.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,78.5
63416,,,5226804,[],CHEMBL1680393,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,92.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,92.5
63417,,,5226807,[],CHEMBL1680394,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,100.0
63418,,,5226816,[],CHEMBL1680524,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,69.8,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,69.8
63419,,,5226820,[],CHEMBL1680525,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,77.4,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,77.4
63420,,,5226824,[],CHEMBL1680526,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,78.4,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,78.4
63421,,,5226828,[],CHEMBL1680527,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,87.4,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,87.4
63422,,,5226832,[],CHEMBL1680528,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,92.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,92.5
63423,,,5226836,[],CHEMBL1680529,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,93.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,93.0
63424,,,5226840,[],CHEMBL1680530,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,96.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,96.0
63425,,,5226847,[],CHEMBL1680532,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,98.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,98.5
63426,,,5226850,[],CHEMBL1680533,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,100.0
63427,,,5226855,[],CHEMBL1680536,Antibacterial activity against Klebsiella oxytoca assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,93.8,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,93.8
63428,,,5226862,[],CHEMBL1680538,Antibacterial activity against Klebsiella oxytoca assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,100.0
63429,,,5226868,[],CHEMBL1680541,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,87.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,87.5
63430,,,5226879,[],CHEMBL1680545,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,91.7,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,91.7
63431,,,5226880,[],CHEMBL1680546,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,93.1,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,93.1
63432,,,5226884,[],CHEMBL1681164,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,97.2,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,97.2
63433,,,5226888,[],CHEMBL1679398,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,98.6,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,98.6
63434,,,5226894,[],CHEMBL1679400,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,100.0
63435,,,5226896,[],CHEMBL1679401,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,33.3,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,33.3
63436,,,5226898,[],CHEMBL1679402,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,63.6,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,63.6
63437,,,5226902,[],CHEMBL1679403,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,75.8,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,75.8
63438,,,5226906,[],CHEMBL1679404,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,78.8,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,78.8
63439,,,5226913,[],CHEMBL1679406,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,84.8,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,84.8
63440,,,5226915,[],CHEMBL1679407,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,93.9,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,93.9
63441,,,5226917,[],CHEMBL1679541,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,97.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,97.0
63442,,,5226922,[],CHEMBL1679543,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,100.0
63443,,,5226926,[],CHEMBL1679545,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,2.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,2.2
63444,,,5226930,[],CHEMBL1679546,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,5.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,5.1
63445,,,5226933,[],CHEMBL1679547,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,10.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,10.2
63446,,,5226937,[],CHEMBL1679548,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,42.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,42.3
63447,,,5226941,[],CHEMBL1679549,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,59.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,59.9
63448,,,5226945,[],CHEMBL1679550,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,70.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,70.1
63449,,,5226949,[],CHEMBL1679551,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,78.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,78.8
63450,,,5226953,[],CHEMBL1679552,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,84.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,84.7
63451,,,5226957,[],CHEMBL1679553,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,90.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,90.5
63452,,,5226960,[],CHEMBL1679554,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 32 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,100.0
63453,,,5226966,[],CHEMBL1679559,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,3.8,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,3.8
63454,,,5226970,[],CHEMBL1679562,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,7.7,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,7.7
63455,,,5226974,[],CHEMBL1679563,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,46.2,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,46.2
63456,,,5226978,[],CHEMBL1679564,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,69.2,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,69.2
63457,,,5226982,[],CHEMBL1679565,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,84.6,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,84.6
63458,,,5226985,[],CHEMBL1679566,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,92.3,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,92.3
63459,,,5226989,[],CHEMBL1679567,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,100.0
63460,,,5226992,[],CHEMBL1679570,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,6.7,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,6.7
63461,,,5226996,[],CHEMBL1679571,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,40.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,40.0
63462,,,5227000,[],CHEMBL1679572,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,80.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,80.0
63463,,,5227004,[],CHEMBL1679704,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,86.7,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,86.7
63464,,,5227008,[],CHEMBL1679705,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,93.3,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,93.3
63465,,,5227012,[],CHEMBL1679708,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332069,=,1,0,=,,Activity,%,,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,100.0
63466,,,5227016,[],CHEMBL1679789,Antibacterial activity against Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332069,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63467,,,5228587,[],CHEMBL1678027,Antimicrobial activity against Haemophilus influenzae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332500,=,1,1,=,,MIC,ug.mL-1,,0.08,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.08
63468,,,5228589,[],CHEMBL1678027,Antimicrobial activity against Haemophilus influenzae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332500,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.06
63469,,,5228591,[],CHEMBL1678027,Antimicrobial activity against Haemophilus influenzae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671722,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332500,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,0.015
63470,,,5228597,[],CHEMBL1678042,"Half life in common marmoset at 40 mg/kg, po measured on day 1 by LS/MS/MS analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,,T1/2,hr,,3.9,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,,t1/2,hr,UO_0000032,,3.9
63471,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5228598,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '40.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '40.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1678043,"Cmax in common marmoset at 40 mg/kg, po measured on day 1 by LS/MS/MS analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,1332502,=,1,1,=,,Cmax,nM,,52024.24,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,,Cmax,ug ml-1,UO_0000065,,18.8
63472,,,5228599,[],CHEMBL1678041,"AUC in common marmoset at 40 mg/kg, po measured on day 1 by LS/MS/MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332502,=,1,1,=,,AUC,ng.hr.mL-1,,112400.0,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,,AUC,ug/ml/hr,,,112.4
63473,,,5228600,[],CHEMBL1678040,"Half life in common marmoset at 40 mg/kg, po BID measured on day 1 by LS/MS/MS analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,,T1/2,hr,,2.4,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,,t1/2,hr,UO_0000032,,2.4
63474,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5228601,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '40.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '40.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1678039,"Cmax in common marmoset at 40 mg/kg, po BID measured on day 1 by LS/MS/MS analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,1332502,=,1,1,=,,Cmax,nM,,45659.57,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,,Cmax,ug ml-1,UO_0000065,,16.5
63475,,,5228602,[],CHEMBL1678038,"AUC in common marmoset at 40 mg/kg, po BID measured on day 1 by LS/MS/MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332502,=,1,1,=,,AUC,ng.hr.mL-1,,63600.0,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,,AUC,ug/ml/hr,,,63.6
63476,,,5228603,[],CHEMBL1678037,"Half life in common marmoset at 40 mg/kg, po BID measured on day 7 by LS/MS/MS analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,,T1/2,hr,,2.3,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,,t1/2,hr,UO_0000032,,2.3
63477,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5228604,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '40.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '40.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1678036,"Cmax in common marmoset at 40 mg/kg, po BID measured on day 7 by LS/MS/MS analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,1332502,=,1,1,=,,Cmax,nM,,57835.46,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,,Cmax,ug ml-1,UO_0000065,,20.9
63478,,,5228605,[],CHEMBL1678035,"AUC in common marmoset at 40 mg/kg, po BID measured on day 7 by LS/MS/MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332502,=,1,1,=,,AUC,ng.hr.mL-1,,81400.0,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,,AUC,ug/ml/hr,,,81.4
63479,,Active,5228606,[],CHEMBL1678056,Antimicrobial activity against Francisella tularensis SCHU S4 infected in common marmoset assessed as survival of marmoset at 16.5 mg/kg BID for 10 days measured on day 24,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332502,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
63480,,,5228607,[],CHEMBL1678034,"Tmax in common marmoset at 40 mg/kg, po BID measured on day 7 by LS/MS/MS analysis",A,,,BAO_0003037,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,,Tmax,hr,,0.5,CHEMBL613924,Callithrix jacchus,Callithrix jacchus,9483.0,,,Tmax,hr,UO_0000032,,0.5
63481,,,5228608,[],CHEMBL1678033,"Half life in human at 500 mg, po QD measured on day 10 by LS/MS/MS analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,,T1/2,hr,,7.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.6
63482,,,5228609,[],CHEMBL1678032,"Tmax in human at 500 mg, po QD measured on day 10 by LS/MS/MS analysis",A,,,BAO_0003037,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,,Tmax,hr,,1.1,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,1.1
63483,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5228610,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '500.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1678030,"Cmax in human at 500 mg, po QD measured on day 10 by LS/MS/MS analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,1332502,=,1,1,=,,Cmax,nM,,15773.31,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,5.7
63484,,,5228611,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '500.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1678031,"AUC (0 to infinity) in human at 500 mg, po QD measured on day 10 by LS/MS/MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332502,=,1,1,=,,AUC,ng.hr.mL-1,,47.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug/L/h,,,47.5
63485,,,5228612,[],CHEMBL1678045,"Half life in human at 500 mg, po by LS/MS/MS analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,,T1/2,hr,,6.4,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,6.4
63486,,,5228613,[],CHEMBL1678044,"Tmax in human at 500 mg, po by LS/MS/MS analysis",A,,,BAO_0003037,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,,Tmax,hr,,1.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,1.5
63487,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5228614,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '500.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1678046,"Cmax in human at 500 mg, po by LS/MS/MS analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,1332502,=,1,1,=,,Cmax,nM,,23521.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,8.5
63488,,,5228615,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '500.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1678047,"AUC (0 to infinity) in human at 500 mg, po by LS/MS/MS analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332502,=,1,1,=,,AUC,ng.hr.mL-1,,56.3,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug/L/h,,,56.3
63489,,,5228616,[],CHEMBL1678048,Half life in Rhesus monkey at 15 mg/kg followed by 4 mg/kg in 12 hrs dosing interval by LS/MS/MS analysis,A,,,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,,T1/2,hr,,3.4,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,t1/2,hr,UO_0000032,,3.4
63490,,,5228617,[],CHEMBL1678049,Tmax in Rhesus monkey at 15 mg/kg followed by 4 mg/kg in 12 hrs dosing interval by LS/MS/MS analysis,A,,,BAO_0003037,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,,Tmax,hr,,2.2,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,Tmax,hr,UO_0000032,,2.2
63491,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5228618,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '15.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '15.0'}]",CHEMBL1678050,Cmax in Rhesus monkey at 15 mg/kg followed by 4 mg/kg in 12 hrs dosing interval by LS/MS/MS analysis,A,,,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,1332502,=,1,1,=,,Cmax,nM,,14666.41,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,Cmax,ug ml-1,UO_0000065,,5.3
63492,,,5228619,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '15.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '15.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1678051,AUC (0 to infinity) in Rhesus monkey at 15 mg/kg followed by 4 mg/kg in 12 hrs dosing interval by LS/MS/MS analysis,A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332502,=,1,1,=,,AUC,ng.hr.mL-1,,33.4,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,AUC,ug/L/h,,,33.4
63493,,,5228620,[],CHEMBL1678052,Half life in Rhesus monkey at 15 mg/kg by LS/MS/MS analysis,A,,,BAO_0002115,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,,T1/2,hr,,2.0,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,t1/2,hr,UO_0000032,,2.0
63494,,,5228621,[],CHEMBL1678053,Tmax in Rhesus monkey at 15 mg/kg by LS/MS/MS analysis,A,,,BAO_0003037,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1332502,=,1,1,=,,Tmax,hr,,1.5,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,Tmax,hr,UO_0000032,,1.5
63495,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5228622,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '15.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '15.0'}]",CHEMBL1678054,Cmax in Rhesus monkey at 15 mg/kg by LS/MS/MS analysis,A,,,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,1332502,=,1,1,=,,Cmax,nM,,14112.96,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,Cmax,ug ml-1,UO_0000065,,5.1
63496,,,5228623,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '15.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '15.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1678055,AUC (0 to infinity) in Rhesus monkey at 15 mg/kg by LS/MS/MS analysis,A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671723,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332502,=,1,1,=,,AUC,ng.hr.mL-1,,21.3,CHEMBL614875,Macaca mulatta,Rhesus monkey,9544.0,,,AUC,ug/L/h,,,21.3
63497,,,5229242,[],CHEMBL1679882,Ratio of MIC for Escherichia coli K-12 3-AG300 harboring acrB::rpsLneo mutant gene to MIC for Escherichia coli K-12 3-AG300,F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1331917,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
63498,,,5229256,[],CHEMBL1679881,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-N623S-Q624S mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
63499,,,5229270,[],CHEMBL1679880,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-G616N mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
63500,,,5229284,[],CHEMBL1679174,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-I626M mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
63501,,,5229298,[],CHEMBL1679173,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-M626I mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
63502,,,5229312,[],CHEMBL1679172,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-N616 mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
63503,,,5229326,[],CHEMBL1679171,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
63504,,,5229340,[],CHEMBL1679170,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring acrB::rpsLneo mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
63505,,,5229354,[],CHEMBL1679169,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-F628F mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
63506,,,5229357,[],CHEMBL1679886,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-S623N mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331917,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
63507,,,5229661,[],CHEMBL1678266,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332114,=,1,0,=,,Activity,%,,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.0
63508,,,5229680,[],CHEMBL1678264,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae assessed as susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332114,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
63509,,,5229694,[],CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332114,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
63510,,,5229703,[],CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332114,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
63511,,,5229715,[],CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332114,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
63512,,,5230118,[],CHEMBL1676244,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZN10 containing cat and bla genes by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332571,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
63513,,,5230119,[],CHEMBL1676245,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2396-encoded QacA gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332571,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
63514,,,5230120,[],CHEMBL1676246,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2182-encoded QacBII gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332571,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
63515,,,5230121,[],CHEMBL1676247,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2162-encoded QacBIII gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332571,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
63516,,,5230122,[],CHEMBL1676248,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2162-encoded QacBIII E320A mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332571,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
63517,,,5230123,[],CHEMBL1676249,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332571,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
63518,,Not Determined,5230124,[],CHEMBL1676250,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV A19T mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332571,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
63519,,Not Determined,5230125,[],CHEMBL1676251,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV S151I mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332571,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
63520,,Not Determined,5230126,[],CHEMBL1676252,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV A184V mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332571,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
63521,,Not Determined,5230127,[],CHEMBL1676253,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV E377G mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332571,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
63522,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5294972,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1697194,"Cmax in Escherichia coli ATCC 35218 infected Wistar rat tissue cage fluid at 100 mg/kg/day, ip measured on day 4",A,,,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,1337257,=,1,1,=,,Cmax,nM,,33206.96,CHEMBL612558,,ADMET,,,,Cmax,mg/L,UO_0000065,,12.0
63523,,,5294973,[],CHEMBL1697195,"Cmin in Escherichia coli ATCC 35218 infected Wistar rat tissue cage fluid at 100 mg/kg/day, ip measured on day 4",A,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,0,=,,Cmin,mg/L,,1.1,CHEMBL612558,,ADMET,,,,Cmin,mg/L,,,1.1
63524,,,5294974,[],CHEMBL1697196,"AUC in Escherichia coli ATCC 35218 infected Wistar rat serum at 100 mg/kg/day, ip measured on day 4",A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,1,=,,AUC,ng.hr.mL-1,,106000.0,CHEMBL613658,Rattus norvegicus,Serum,10116.0,,,AUC,microg.hr/mL,,,106.0
63525,,,5294975,[],CHEMBL1697197,"AUC in Escherichia coli ATCC 35218 infected Wistar rat tissue cage fluid at 100 mg/kg/day, ip measured on day 4",A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,1,=,,AUC,ng.hr.mL-1,,117000.0,CHEMBL612558,,ADMET,,,,AUC,microg.hr/mL,,,117.0
63526,,,5294976,[],CHEMBL1697198,"Ratio of AUC in Wistar rat tissue cage fluid to MIC for Escherichia coli ATCC 35218 at 100 mg/kg/day, ip measured on day 4",F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,0,=,,Ratio,,,234.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,234.0
63527,,,5294977,[],CHEMBL1697199,"Ratio of Cmax in Wistar rat tissue cage fluid to MIC for Escherichia coli ATCC 35218 at 100 mg/kg/day, ip measured on day 4",F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,0,=,,Ratio,,,24.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,24.0
63528,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5294978,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg/kg/day', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg/day', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1697200,"Cmax in Escherichia coli ATCC 35218 infected Wistar rat tissue cage fluid at 50 mg/kg/day, ip measured on day 4",A,,,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,1337257,=,1,1,=,,Cmax,nM,,16603.48,CHEMBL612558,,ADMET,,,,Cmax,mg/L,UO_0000065,,6.0
63529,,,5294979,[],CHEMBL1697201,"Cmin in Escherichia coli ATCC 35218 infected Wistar rat tissue cage fluid at 50 mg/kg/day, ip measured on day 4",A,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,0,=,,Cmin,mg/L,,0.6,CHEMBL612558,,ADMET,,,,Cmin,mg/L,,,0.6
63530,,,5294980,[],CHEMBL1697202,"AUC in Escherichia coli ATCC 35218 infected Wistar rat serum at 50 mg/kg/day, ip measured on day 4",A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,1,=,,AUC,ng.hr.mL-1,,77000.0,CHEMBL613658,Rattus norvegicus,Serum,10116.0,,,AUC,microg.hr/mL,,,77.0
63531,,,5294981,[],CHEMBL1697203,"AUC in Escherichia coli ATCC 35218 infected Wistar rat tissue cage fluid at 50 mg/kg/day, ip measured on day 4",A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,1,=,,AUC,ng.hr.mL-1,,68000.0,CHEMBL612558,,ADMET,,,,AUC,microg.hr/mL,,,68.0
63532,,,5294982,[],CHEMBL1697204,"Ratio of AUC in Wistar rat tissue cage fluid to MIC for Escherichia coli ATCC 35218 at 50 mg/kg/day, ip measured on day 4",F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,0,=,,Ratio,,,136.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,136.0
63533,,,5294983,[],CHEMBL1697205,"Ratio of Cmax in Wistar rat tissue cage fluid to MIC for Escherichia coli ATCC 35218 at 50 mg/kg/day, ip measured on day 4",F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,0,=,,Ratio,,,13.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,13.0
63534,,,5294991,[],CHEMBL1697192,Antimicrobial activity against log phase culture of methicillin-resistant Staphylococcus aureus ATCC 29213 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337257,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
63535,,,5294992,[],CHEMBL1697192,Antimicrobial activity against log phase culture of methicillin-resistant Staphylococcus aureus ATCC 29213 by macrodilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337257,=,1,0,=,,MBC,ug ml-1,,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.015
63536,,,5294994,[],CHEMBL1697190,Antimicrobial activity against stationary phase culture of methicillin-resistant Staphylococcus aureus ATCC 29213 by macrodilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337257,>,1,0,>,,MBC,ug ml-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,8.0
63537,,Not Active,5294998,[],CHEMBL1697193,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 at 2 times MIC in presence of rifampin,F,,,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337257,,1,0,,,Inhibition,%,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,INH,,UO_0000187,,
63538,,,5294999,[],CHEMBL1697187,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 tissue cage Wistar rat infected model assessed as bacterial load reduction at 100 mg/kg/day, ip treated for 7 days measured 24 hrs after last dose (Rvb = 6.8 +/-0.8 logCFU/ml)",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,0,=,,log10CFU/ml,,,6.74,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,6.74
63539,,,5295000,[],CHEMBL1697186,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 tissue cage Wistar rat infected model assessed as bacterial load reduction at 50 mg/kg/day, ip treated for 7 days measured 24 hrs after last dose (Rvb = 6.8 +/-0.8 logCFU/ml)",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,0,=,,log10CFU/ml,,,6.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,6.4
63540,,,5295001,[],CHEMBL1697336,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 tissue cage Wistar rat infected model assessed as bacterial load reduction at 100 mg/kg/day, ip treated for 7 days measured 24 hrs after last dose (Rvb = 6.8 +/-0.8 logCFU/ml) co-treated with 25 mg/kg rifampin, ip bid",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,0,=,,log10CFU/ml,,,6.74,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,6.74
63541,,,5295002,[],CHEMBL1697337,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 tissue cage Wistar rat infected model assessed as bacterial load reduction at 50 mg/kg/day, ip treated for 7 days measured 24 hrs after last dose (Rvb = 6.8 +/-0.8 logCFU/ml) co-treated with 25 mg/kg rifampin, ip bid",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,0,=,,log10CFU/ml,,,6.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,6.7
63542,,,5295003,[],CHEMBL1697338,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 tissue cage Wistar rat infected model assessed as bacterial load reduction at 100 mg/kg/day, ip treated for 14 days measured 24 hrs after last dose (Rvb = 7.2 +/- 0.6 logCFU/ml) co-treated with 25 mg/kg rifampin, ip bid",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,0,=,,log10CFU/ml,,,3.37,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.37
63543,,,5295004,[],CHEMBL1697185,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 tissue cage Wistar rat infected model assessed as bacterial load reduction at 100 mg/kg/day, ip treated for 14 days measured 24 hrs after last dose (Rvb = 7.2 +/- 0.6 logCFU/ml)",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,0,=,,log10CFU/ml,,,2.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.9
63544,,,5295005,[],CHEMBL1697184,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 coverslip Wistar rat infected model assessed as bacterial load reduction at 100 mg/kg/day, ip treated for 14 days measured 24 hrs after last dose (Rvb = 5.4 +/- 1 logCFU/ml)",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,0,=,,log10CFU/ml,,,2.24,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.24
63545,,,5295006,[],CHEMBL1697339,"Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 coverslip Wistar rat infected model assessed as bacterial load reduction at 100 mg/kg/day, ip treated for 14 days measured 24 hrs after last dose (Rvb = 5.4 +/- 1 logCFU/ml) co-treated with 25 mg/kg rifampin, ip bid",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687713,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1337257,=,1,0,=,,log10CFU/ml,,,3.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.3
63546,,,5296292,[],CHEMBL1691259,Bacteriostatic activity against Escherichia coli K-12 DM4100,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687807,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338187,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.2
63547,,,5296307,[],CHEMBL1691260,Bactericidal activity against Escherichia coli K-12 DM4100 after 2 hrs in presence of protein synthesis inhibitor chloramphenicol treated 10 mins before compound challenge,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687807,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338187,=,1,0,=,,LD99,ug ml-1,,0.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,LD99,ug ml-1,UO_0000274,,0.8
63548,,,5296322,[],CHEMBL1691261,Ratio of LD99 for Escherichia coli K-12 DM4100 to MIC for Escherichia coli K-12 DM4100,F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687807,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1338187,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
63549,,,5297846,[],CHEMBL1690705,Antimicrobial activity against Acinetobacter lwoffii isolate A expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,8.0
63550,,,5297847,[],CHEMBL1690706,Antimicrobial activity against Acinetobacter lwoffii isolate B expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,8.0
63551,,,5297848,[],CHEMBL1690707,Antimicrobial activity against Acinetobacter lwoffii isolate C expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,8.0
63552,,,5297849,[],CHEMBL1690708,Antimicrobial activity against Acinetobacter lwoffii isolate D expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,8.0
63553,,,5297850,[],CHEMBL1690709,Antimicrobial activity against Acinetobacter lwoffii isolate E expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,16.0
63554,,,5297851,[],CHEMBL1690710,Antimicrobial activity against Acinetobacter lwoffii isolate F expressing beta-lactamase OXA-164 isolated from tracheostoma of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,8.0
63555,,,5297852,[],CHEMBL1690711,Antimicrobial activity against Acinetobacter lwoffii isolate G expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,64.0
63556,,,5297853,[],CHEMBL1690712,Antimicrobial activity against Acinetobacter lwoffii isolate H expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,64.0
63557,,,5298585,[],CHEMBL1690713,Antimicrobial activity against Acinetobacter lwoffii isolate I expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,64.0
63558,,,5298586,[],CHEMBL1690714,Antimicrobial activity against Acinetobacter lwoffii isolate J expressing beta-lactamase OXA-58 isolated from bedsore by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,64.0
63559,,,5298587,[],CHEMBL1690715,Antimicrobial activity against Acinetobacter lwoffii isolate K expressing beta-lactamase OXA-58 isolated from blood culture of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,64.0
63560,,,5298588,[],CHEMBL1690716,Antimicrobial activity against Acinetobacter lwoffii isolate L expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,64.0
63561,,,5298589,[],CHEMBL1690717,Antimicrobial activity against Acinetobacter lwoffii isolate M expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338301,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,64.0
63562,,,5305664,[],CHEMBL1690402,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae ATCC 138821 by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.03
63563,,,5305665,[],CHEMBL1690403,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj1 expressing efflux system by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,1.0
63564,,,5305666,[],CHEMBL1690404,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.03
63565,,,5305667,[],CHEMBL1690405,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj1 expressing efflux system by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,1.0
63566,,,5305668,[],CHEMBL1690406,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.06
63567,,,5305669,[],CHEMBL1690407,"Antibacterial activity against porin, OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.5
63568,,,5305670,[],CHEMBL1690408,"Antibacterial activity against porin, OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.03
63569,,,5305671,[],CHEMBL1690409,Antibacterial activity against porin deficient OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 expressing efflux system by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,1.0
63570,,,5305672,[],CHEMBL1690410,Antibacterial activity against porin deficient OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.06
63571,,,5305673,[],CHEMBL1690411,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj3 expressing efflux system by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.5
63572,,,5305674,[],CHEMBL1690412,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj3 revertant by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.03
63573,,,5305675,[],CHEMBL1690413,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj3 expressing efflux system by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.5
63574,,,5305676,[],CHEMBL1690414,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj3 revertant by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.015
63575,,,5305677,[],CHEMBL1690415,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj5 expressing efflux system by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.125
63576,,,5305678,[],CHEMBL1690416,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj5 revertant by disk agar diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.06
63577,,,5305679,[],CHEMBL1690417,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj5 expressing efflux system by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.125
63578,,,5305680,[],CHEMBL1690418,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj5 revertant by disk agar diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687777,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337863,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mg/L,UO_0000274,,0.06
63579,,,5307391,[],CHEMBL1694333,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
63580,,,5307392,[],CHEMBL1694334,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
63581,,,5307393,[],CHEMBL1694335,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
63582,,,5307394,[],CHEMBL1694336,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
63583,,,5307395,[],CHEMBL1694337,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
63584,,,5307396,[],CHEMBL1694221,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
63585,,,5307397,[],CHEMBL1694220,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
63586,,,5307398,[],CHEMBL1694219,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
63587,,,5307399,[],CHEMBL1694218,Antibacterial activity against Escherichia coli ATCC 25922 harboring ParC S80R mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
63588,,,5307400,[],CHEMBL1694332,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
63589,,,5307401,[],CHEMBL1694223,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
63590,,,5307402,[],CHEMBL1694217,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
63591,,,5307403,[],CHEMBL1694338,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant and ParC S80R mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
63592,,,5307404,[],CHEMBL1694339,"Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrA1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
63593,,,5307405,[],CHEMBL1694340,"Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrB1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
63594,,,5307406,[],CHEMBL1694341,"Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrS1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
63595,,,5307407,[],CHEMBL1694346,Antibacterial activity against Escherichia coli ATCC 25922 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,Activity,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,2.0
63596,,,5307408,[],CHEMBL1694347,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,Activity,ug ml-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,8.0
63597,,,5307409,[],CHEMBL1694348,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,4.0
63598,,,5307410,[],CHEMBL1694527,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,4.0
63599,,,5307411,[],CHEMBL1694528,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,4.0
63600,,,5307412,[],CHEMBL1694624,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,Activity,ug ml-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,32.0
63601,,,5307413,[],CHEMBL1694625,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,16.0
63602,,,5307414,[],CHEMBL1694626,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,16.0
63603,,,5307415,[],CHEMBL1694627,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922,F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1338561,=,1,0,=,,Ratio,,,250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,250.0
63604,,,5307416,[],CHEMBL1694628,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1,F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1338561,=,1,0,=,,Ratio,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,16.0
63605,,,5307417,[],CHEMBL1694629,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1,F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1338561,=,1,0,=,,Ratio,,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,32.0
63606,,,5307418,[],CHEMBL1694630,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1,F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1338561,=,1,0,=,,Ratio,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,8.0
63607,,,5307419,[],CHEMBL1694631,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 harboring GyrA S83L mutant,F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1338561,=,1,0,=,,Ratio,,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,32.0
63608,,,5307420,[],CHEMBL1694632,Ratio of mutant prevention concentration to MIC for qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1,F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1338561,=,1,0,=,,Ratio,,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,64.0
63609,,,5307421,[],CHEMBL1694633,Ratio of mutant prevention concentration to MIC for qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1,F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1338561,=,1,0,=,,Ratio,,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,64.0
63610,,,5307422,[],CHEMBL1694634,Ratio of mutant prevention concentration to MIC for qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1,F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1338561,=,1,0,=,,Ratio,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,16.0
63611,,,5307423,[],CHEMBL1694635,Antibacterial activity against Escherichia coli ATCC 25922 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,,TIME,hr,,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,48.0
63612,,,5307424,[],CHEMBL1694636,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
63613,,,5307425,[],CHEMBL1694637,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,,TIME,hr,,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,48.0
63614,,,5307426,[],CHEMBL1694638,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
63615,,,5307427,[],CHEMBL1694639,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
63616,,,5307428,[],CHEMBL1694640,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
63617,,,5307429,[],CHEMBL1694641,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,,TIME,hr,,72.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,72.0
63618,,,5307430,[],CHEMBL1694642,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1338561,=,1,1,=,,TIME,hr,,96.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,96.0
63619,,,5307431,[],CHEMBL1694643,Antibacterial activity against Escherichia coli ATCC 25922 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
63620,,,5307432,[],CHEMBL1694644,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
63621,,,5307433,[],CHEMBL1694646,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
63622,,,5307434,[],CHEMBL1694647,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
63623,,,5307435,[],CHEMBL1694648,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
63624,,,5307436,[],CHEMBL1694649,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
63625,,,5307437,[],CHEMBL1694650,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
63626,,,5307438,[],CHEMBL1694651,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
63627,,,5307439,[],CHEMBL1694333,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.03
63628,,,5307440,[],CHEMBL1694334,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
63629,,,5307441,[],CHEMBL1694335,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.25
63630,,,5307442,[],CHEMBL1694336,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
63631,,,5307443,[],CHEMBL1694337,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.25
63632,,,5307444,[],CHEMBL1694221,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
63633,,,5307445,[],CHEMBL1694220,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
63634,,,5307446,[],CHEMBL1694219,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,2.0
63635,,,5307447,[],CHEMBL1694218,Antibacterial activity against Escherichia coli ATCC 25922 harboring ParC S80R mutant by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.008
63636,,,5307448,[],CHEMBL1694332,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
63637,,,5307449,[],CHEMBL1694223,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
63638,,,5307450,[],CHEMBL1694217,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.25
63639,,,5307451,[],CHEMBL1694338,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant and ParC S80R mutant by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.25
63640,,,5307452,[],CHEMBL1694339,"Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrA1 by broth microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,4.0
63641,,,5307453,[],CHEMBL1694340,"Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrB1 by broth microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,1.0
63642,,,5307454,[],CHEMBL1694341,"Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrS1 by broth microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338561,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,4.0
63643,,,5310829,[],CHEMBL1694744,"Treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as phlebitis at 250 mg/kg, iv qd for 10 days",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,4.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,4.0
63644,,,5310830,[],CHEMBL1694743,"Treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as nausea at 250 mg/kg, iv qd for 10 days",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,5.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,5.9
63645,,,5310831,[],CHEMBL1694742,"Treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as upper abdominal pain at 250 mg/kg, iv qd for 10 days",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,3.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,3.5
63646,,,5310832,[],CHEMBL1694739,"Treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as constipation at 250 mg/kg, iv qd for 10 days",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,4.8,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,4.8
63647,,,5310833,[],CHEMBL1694741,"Treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as vomiting at 250 mg/kg, iv qd for 10 days",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,4.3,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,4.3
63648,,,5310834,[],CHEMBL1694740,"Treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as diarrhea at 250 mg/kg, iv qd for 10 days",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,9.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,9.9
63649,,,5310835,[],CHEMBL1694738,"Treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as headache at 250 mg/kg, iv qd for 10 days",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,14.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,14.5
63650,,,5310849,[],CHEMBL1694724,Antibacterial activity against levofloxacin-resistant Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
63651,,,5310850,[],CHEMBL1694723,Antibacterial activity against levofloxacin-resistant Proteus mirabilis,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,32.0
63652,,,5310851,[],CHEMBL1694722,Antibacterial activity against levofloxacin-resistant Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
63653,,,5310852,[],CHEMBL1694721,Antibacterial activity against levofloxacin-resistant Enterococcus faecalis,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,16.0
63654,,,5310854,[],CHEMBL1694719,"Antibacterial activity against Pseudomonas aeruginosa isolated from patient with urinary tract infection receiving drug at 250 mg, iv qd for 10 days measured after post drug therapy",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
63655,,,5310855,[],CHEMBL1694718,"Antibacterial activity against Proteus mirabilis isolated from patient with urinary tract infection receiving drug at 250 mg, iv qd for 10 days measured after post drug therapy",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.25
63656,,,5310856,[],CHEMBL1694717,"Antibacterial activity against Klebsiella pneumoniae isolated from patient with urinary tract infection receiving drug at 250 mg, iv qd for 10 days measured after post drug therapy",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
63657,,,5310857,[],CHEMBL1694716,"Antibacterial activity against Escherichia coli isolated from patient with urinary tract infection receiving drug at 250 mg, iv qd for 10 days measured after post drug therapy",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337509,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
63658,,,5310860,[],CHEMBL1694713,"Antibacterial activity against Proteus mirabilis infected in microbiologically evaluable patient with UTI assessed as cure rate at 250 mg, iv qd for 10 days measured at test-of-cure visit",F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,86.7,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,86.7
63659,,,5310862,[],CHEMBL1694711,"Antibacterial activity against Klebsiella pneumoniae infected in microbiologically evaluable patient with UTI assessed as cure rate at 250 mg, iv qd for 10 days measured at test-of-cure visit",F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,62.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,62.5
63660,,,5310864,[],CHEMBL1694709,"Antibacterial activity against levofloxacin-resistant Escherichia coli infected in clinically evaluable patient with UTI assessed as cure rate at 250 mg, iv qd for 10 days measured at test-of-cure visit",F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,33.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,33.0
63661,,,5310866,[],CHEMBL1694707,"Antibacterial activity against levofloxacin-resistant Escherichia coli infected in microbiologically evaluable patient with UTI assessed as cure rate at 250 mg, iv qd for 10 days measured at test-of-cure visit",F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,29.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,29.0
63662,,,5310868,[],CHEMBL1694705,"Antibacterial activity against Escherichia coli infected in microbiologically evaluable patient with UTI assessed as cure rate at 250 mg, iv qd for 10 days measured at test-of-cure visit",F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,87.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,87.2
63663,,,5310873,[],CHEMBL1694745,"Treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as insomnia at 250 mg/kg, iv qd for 10 days",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,3.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,3.0
63664,,,5310874,[],CHEMBL1694746,"Treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as urinary tract infection at 250 mg/kg, iv qd for 10 days",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,1.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,1.6
63665,,,5310875,[],CHEMBL1694747,"Treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as asymptomatic bacteriuria at 250 mg/kg, iv qd for 10 days",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,1.1,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,1.1
63666,,,5310876,[],CHEMBL1694748,"Treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as back pain at 250 mg/kg, iv qd for 10 days",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,4.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,4.6
63667,,,5310877,[],CHEMBL1694749,"Treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as hypokalemia at 250 mg/kg, iv qd for 10 days",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,3.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,3.5
63668,,,5310878,[],CHEMBL1694750,"Treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as abdominal pain at 250 mg/kg, iv qd for 10 days",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,3.5,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,3.5
63669,,,5310880,[],CHEMBL1694752,"Treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as >=1 adverse event at 250 mg/kg, iv qd for 10 days",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,60.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,60.0
63670,,,5310882,[],CHEMBL1694754,"Drug related treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as >=1 adverse event at 250 mg/kg, iv qd for 10 days",T,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,25.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,25.0
63671,,,5310884,[],CHEMBL1694816,"Drug related treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as headache at 250 mg/kg, iv qd for 10 days",T,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,2.7,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,2.7
63672,,,5310886,[],CHEMBL1694818,"Drug related treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as diarrhea at 250 mg/kg, iv qd for 10 days",T,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,5.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,5.9
63673,,,5310888,[],CHEMBL1694820,"Drug related treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as upper abdominal pain at 250 mg/kg, iv qd for 10 days",T,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,2.2,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,2.2
63674,,,5310890,[],CHEMBL1694822,"Drug related treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as nausea at 250 mg/kg, iv qd for 10 days",T,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,1.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,1.6
63675,,,5310892,[],CHEMBL1694824,"Drug related treatment emergent adverse event in intent-to-treat patient with complicated urinary tract infection assessed as phlebitis at 250 mg/kg, iv qd for 10 days",T,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1687743,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1337509,=,1,0,=,,Activity,%,,3.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,3.0
63676,,Negative,5315922,[],CHEMBL1697691,Literature-mined public compounds from Lowe et al phospholipidosis modelling dataset,A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697681,Mol Pharm,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1339730,,1,0,,,Phospholipidosis,,,,CHEMBL1626541,,Phospholipidosis,,,,Phospholipidosis,,,,
63677,,WE: Weak evidence (<10 case reports) of human hepatotoxicity,5316449,[],CHEMBL1697722,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697692,Chem Res Toxicol,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1340272,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
63678,,DILI negative (training set),5316663,[],CHEMBL1697730,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,A,,,BAO_0000179,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697723,Drug Metab Dispos,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1340481,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
63679,,drug-induced liver injury reported,5317522,[],CHEMBL1697778,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",A,,,BAO_0000179,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1341308,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
63680,,no drug-induced liver injury reported,5318473,[],CHEMBL1697779,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1341308,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
63681,,no drug-induced liver injury reported,5319424,[],CHEMBL1697780,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1341308,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
63682,,Inactive,5325374,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,,1,0,,,Composite Activity - Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Score,,,,
63683,,,5325375,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,=,1,0,=,,Composite Activity - Active,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Active,,,,0.0
63684,,,5325376,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,=,1,0,=,,Composite Activity - Marginal,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Marginal,,,,0.0
63685,,Inactive,5325377,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,,1,0,,,Alkaline Phosphatase Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Activity Score,,,,
63686,,,5325378,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,=,1,0,=,,Alkaline Phosphatase Increase - Index Value,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Index Value,,,,0.0
63687,,,5325379,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,<,1,0,<,,Alkaline Phosphatase Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Number of Reports,,,,4.0
63688,,Inactive,5325380,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,,1,0,,,SGOT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Activity Score,,,,
63689,,,5325381,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,=,1,0,=,,SGOT Increase - Index Value,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Index Value,,,,0.0
63690,,,5325382,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,<,1,0,<,,SGOT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Number of Reports,,,,4.0
63691,,Inactive,5325383,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,,1,0,,,SGPT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Activity Score,,,,
63692,,,5325384,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,=,1,0,=,,SGPT Increase - Index Value,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Index Value,,,,0.0
63693,,,5325385,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,<,1,0,<,,SGPT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Number of Reports,,,,4.0
63694,,Inactive,5325386,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,,1,0,,,LDH Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Activity Score,,,,
63695,,,5325387,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,=,1,0,=,,LDH Increase - Index Value,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Index Value,,,,0.0
63696,,,5325388,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,<,1,0,<,,LDH Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Number of Reports,,,,4.0
63697,,Inactive,5325389,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,,1,0,,,GGT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Activity Score,,,,
63698,,,5325390,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,=,1,0,=,,GGT Increase - Index Value,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Index Value,,,,0.0
63699,,,5325391,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342270,<,1,0,<,,GGT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Number of Reports,,,,4.0
63700,,Negative: confirmed by electron microscopy,5328981,[],CHEMBL1697855,Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset,A,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1697821,Toxicol Mech Methods,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1342560,,1,0,,,Phospholipidosis,,,,CHEMBL1626541,,Phospholipidosis,,,,Phospholipidosis,,,,
63701,,inconclusive,5353823,[],CHEMBL1737991,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1201862,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,1212704,,7,1,,,Potency,nM,,89125.1,CHEMBL5896,Homo sapiens,Lysine-specific demethylase 4A,9606.0,,,Potency,uM,UO_0000065,,89.1251
63702,,inconclusive,5515017,[],CHEMBL1738606,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398],F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1201862,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,1150792,,7,1,,,Potency,nM,,17782.8,CHEMBL5501,Homo sapiens,Histone acetyltransferase GCN5,9606.0,,,Potency,uM,UO_0000065,,17.7828
63703,,inconclusive,5771534,[],CHEMBL1738442,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1201862,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,1150792,,7,1,,,Potency,nM,,8912.5,CHEMBL6032,Homo sapiens,"Histone-lysine N-methyltransferase, H3 lysine-9 specific 3",9606.0,,,Potency,uM,UO_0000065,,8.9125
63704,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",transporter substrate,6073616,[],CHEMBL1743150,"Substrates of transporters of clinical importance in the absorption and disposition of drugs, OATP1A2",A,,,BAO_0000375,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1743141,Nat Rev Drug Discov,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1393629,,1,0,,,Activity,,,,CHEMBL1743123,Homo sapiens,Solute carrier organic anion transporter family member 1A2,9606.0,,,Activity,,,,
63705,,,6172601,[],CHEMBL1767999,Antimicrobial activity against Bacillus cereus ATCC 11778 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.15
63706,,,6172610,[],CHEMBL1768000,Antimicrobial activity against Bacillus megaterium ATCC 19213 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,,MIC,ug ml-1,UO_0000274,,0.03
63707,,,6172619,[],CHEMBL1768001,Antimicrobial activity against Bacillus subtilis ATCC 6633 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.03
63708,,,6172628,[],CHEMBL1768002,Antimicrobial activity against Bacillus thuringiensis var.kurstaki BGSC 4D1 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,,MIC,ug.mL-1,,0.07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.07
63709,,,6172637,[],CHEMBL1768003,Antimicrobial activity against Staphylococcus aureus ATCC 6538 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,,MIC,ug.mL-1,,0.07,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.07
63710,,,6172646,[],CHEMBL1768004,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus aureus isolate SAR 72 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
63711,,,6172655,[],CHEMBL1768005,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus aureus isolate SAR 4790 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
63712,,,6172664,[],CHEMBL1768006,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.15
63713,,,6172673,[],CHEMBL1768007,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus epidermidis clinical isolate by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,100.0
63714,,,6172682,[],CHEMBL1768008,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.15
63715,,,6172691,[],CHEMBL1768009,Antimicrobial activity against quinilone-pencillin-resistant Acinetobacter baumannii clinical isolate by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,100.0
63716,,,6172700,[],CHEMBL1768010,Antimicrobial activity against Escherichia coli ATCC 8739 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
63717,,,6172709,[],CHEMBL1768011,Antimicrobial activity against quinilone-pencillin-resistant Escherichia coli clinical isolate by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,25.0
63718,,,6172718,[],CHEMBL1768012,Antimicrobial activity against Haemophilus influenzae ATCC 19418 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.15
63719,,,6172727,[],CHEMBL1768013,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.3
63720,,,6172736,[],CHEMBL1768014,Antimicrobial activity against Saccharomyces cerevisiae ATCC 9763 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,100.0
63721,,,6172746,[],CHEMBL1768015,Antimicrobial activity against Candida tropicalis ATCC 1369 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL612870,Candida tropicalis,Candida tropicalis,5482.0,,,MIC,ug ml-1,UO_0000274,,100.0
63722,,,6172756,[],CHEMBL1768201,Antimicrobial activity against Aspergillus niger ATCC 6275 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418180,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,,MIC,ug ml-1,UO_0000274,,100.0
63723,,,6184781,[],CHEMBL1775356,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1422183,>,1,1,>,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
63724,,,6184787,[],CHEMBL1775356,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate after 24 hrs by microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1422183,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,16.0
63725,,,6184793,[],CHEMBL1775356,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate after 24 hrs by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1422183,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,16.0
63726,,,6208995,[],CHEMBL1781603,Antibacterial activity against Staphylococcus aureus ATCC 13709,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
63727,,,6208996,[],CHEMBL1781602,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 08-49,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
63728,,,6208997,[],CHEMBL1781604,Antibacterial activity against methicillin-resistant Staphylococcus aureus 08-52,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
63729,,,6208998,[],CHEMBL1781605,Antibacterial activity against Staphylococcus epidermidis ATCC 12228,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
63730,,,6208999,[],CHEMBL1781606,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 08-17,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
63731,,,6209000,[],CHEMBL1781746,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 08-18,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
63732,,,6209001,[],CHEMBL1781747,Antibacterial activity against Streptococcus pneumoniae ATCC 6301,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
63733,,,6209002,[],CHEMBL1781748,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 08-2,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
63734,,,6209003,[],CHEMBL1781749,Antibacterial activity against Enterococcus faecalis ATCC 51299,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
63735,,,6209004,[],CHEMBL1781750,Antibacterial activity against vancomycin-resistant Enterococcus faecalis EFL1004,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.0
63736,,,6209005,[],CHEMBL1781751,Antibacterial activity against Streptococcus pyogenes 556,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,1.0
63737,,,6209006,[],CHEMBL1781752,Antibacterial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
63738,,,6209007,[],CHEMBL1781753,Antibacterial activity against Extended spectrum beta-lactamase producing Escherichia coli 08-5,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
63739,,,6209008,[],CHEMBL1781754,Antibacterial activity against Klebsiella pneumoniae ATCC 700603,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
63740,,,6209009,[],CHEMBL1781755,Antibacterial activity against Pseudomonas aeruginosa 17,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
63741,,,6209010,[],CHEMBL1781756,Antibacterial activity against Shigella sonnei 51592,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,MIC,ug ml-1,UO_0000274,,0.03
63742,,,6209011,[],CHEMBL1781757,Antibacterial activity against Bacillus typhi 50035,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,0.03
63743,,,6209012,[],CHEMBL1781758,Antibacterial activity against Enterobacter cloacae 45301,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.06
63744,,,6209013,[],CHEMBL1781759,Antibacterial activity against Acinetobacter calcoaceticus 25001,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC,ug ml-1,UO_0000274,,0.25
63745,,,6209014,[],CHEMBL1781760,Antibacterial activity against Enterobacter aerogenes 45102,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.03
63746,,,6209015,[],CHEMBL1781761,Antibacterial activity against Serratia marcescens 41002,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.25
63747,,,6209016,[],CHEMBL1781762,Antibacterial activity against Morganella morganii 49086,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.03
63748,,,6209017,[],CHEMBL1781763,Antibacterial activity against Proteus rettgeri 49006,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.25
63749,,,6209018,[],CHEMBL1781764,Antibacterial activity against Proteus vulgaris 56,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424190,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.03
63750,,,6229804,[],CHEMBL1785609,Antibacterial activity against 10'4 CFU Staphylococcus aureus ATCC 25923 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
63751,,,6229805,[],CHEMBL1785610,Antibacterial activity against 10'4 CFU methicillin-sensitive Staphylococcus aureus 08-1 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
63752,,,6229806,[],CHEMBL1785772,Antibacterial activity against 10'4 CFU methicillin-resistant Staphylococcus aureus 08-1 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
63753,,,6229807,[],CHEMBL1785773,Antibacterial activity against 10'4 CFU methicillin-sensitive Staphylococcus epidermidis 09-6 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,4.0
63754,,,6229808,[],CHEMBL1785774,Antibacterial activity against 10'4 CFU methicillin-resistant Staphylococcus epidermidis 09-2 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
63755,,,6229809,[],CHEMBL1785775,Antibacterial activity against 10'4 CFU Streptococcus pneumoniae 08-4 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
63756,,,6229810,[],CHEMBL1785776,Antibacterial activity against 10'4 CFU Enterococcus faecalis 08-10 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
63757,,,6229811,[],CHEMBL1785777,Antibacterial activity against 10'4 CFU Enterococcus faecalis 08-12 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
63758,,,6229812,[],CHEMBL1785778,Antibacterial activity against 10'4 CFU Enterococcus faecium 08-2 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,4.0
63759,,,6229813,[],CHEMBL1785779,Antibacterial activity against 10'4 CFU Enterococcus faecium 06-7 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,16.0
63760,,,6229814,[],CHEMBL1785780,Antibacterial activity against 10'4 CFU Escherichia coli ATCC 25922 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
63761,,,6229815,[],CHEMBL1785781,Antibacterial activity against 10'4 CFU Escherichia coli 08-21 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
63762,,,6229816,[],CHEMBL1785782,Antibacterial activity against 10'4 CFU Klebsiella pneumoniae 09-22 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
63763,,,6229817,[],CHEMBL1785783,Antibacterial activity against 10'4 CFU Klebsiella pneumoniae 09-23 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
63764,,,6229818,[],CHEMBL1785784,Antibacterial activity against 10'4 CFU Pseudomonas aeruginosa ATCC 27853 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
63765,,,6229819,[],CHEMBL1785785,Antibacterial activity against 10'4 CFU Pseudomonas aeruginosa 09-32 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427625,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
63766,,,6262180,[],CHEMBL1798462,Unbound drug concentration in Sprague-Dawley rat plasma administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method,A,,,BAO_0000179,BAO_0000366,cell-free format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1795238,J Med Chem,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Micromolar,1438387,=,1,0,=,,Cp(f),uM,,0.59,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,Cp(f),uM,UO_0000064,,0.59
63767,,,6262223,[],CHEMBL1798463,Unbound volume of distribution in Sprague-Dawley rat brain measured per gram of brain tissue administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method,A,,,BAO_0000179,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1795238,J Med Chem,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1438387,=,1,0,=,,Vdu,ml,,1.7,CHEMBL613617,Rattus norvegicus,Brain,10116.0,,,Vdu,ml,UO_0000098,,1.7
63768,,,6262266,[],CHEMBL1798464,Fraction unbound in Sprague-Dawley rat plasma administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method,A,,,BAO_0000179,BAO_0000366,cell-free format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1795238,J Med Chem,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1438387,=,1,1,=,,Fu,,,0.82,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,Fu,,,,0.82
63769,,,6262309,[],CHEMBL1798465,Ratio of total drug level in brain to plasma in Sprague-Dawley rat administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method,A,,,BAO_0000179,BAO_0000366,cell-free format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1795238,J Med Chem,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1438387,=,1,0,=,,BPR,,,0.17,CHEMBL612558,,ADMET,,,,BPR,,,,0.17
63770,,,6262352,[],CHEMBL1798466,Unbound brain to plasma concentration ratio in Sprague-Dawley rat administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr,A,,,BAO_0000179,BAO_0000366,cell-free format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1795238,J Med Chem,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1438387,=,1,0,=,,"K(p,uu,brain)",,,0.12,CHEMBL612558,,ADMET,,,,"K(p,uu,brain)",,,,0.12
63771,,,6262394,[],CHEMBL1798467,Unbound CSF to plasma concentration ratio in Sprague-Dawley rat administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method,A,,,BAO_0000179,BAO_0000366,cell-free format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1795238,J Med Chem,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1438387,=,1,0,=,,"K(p,uu,CSF)",,,0.19,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,"K(p,uu,CSF)",,,,0.19
63772,,,6262434,[],CHEMBL1798468,Unbound CSF to plasma concentration ratio in human,A,,,BAO_0000179,BAO_0000366,cell-free format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1795238,J Med Chem,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1438387,=,1,0,=,,"K(p,uu,CSF)",,,0.18,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,"K(p,uu,CSF)",,,,0.18
63773,,,6268566,[],CHEMBL1803851,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1799937,J Nat Prod,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
63774,,,6268567,[],CHEMBL1803852,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1799937,J Nat Prod,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
63775,,,6268568,[],CHEMBL1803853,Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1799937,J Nat Prod,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.12
63776,,,6268569,[],CHEMBL1803854,Antibacterial activity against Mycobacterium smegmatis MC2 155 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1799937,J Nat Prod,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,1.0
63777,,,6268570,[],CHEMBL1803855,Antibacterial activity against Mycobacterium tuberculosis H37Rv after 14 days by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1799937,J Nat Prod,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
63778,,,6268571,[],CHEMBL1804001,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1799937,J Nat Prod,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
63779,,,6268572,[],CHEMBL1804002,Antibacterial activity against multidrug-resistant Morganella morganii 07-09 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1799937,J Nat Prod,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,16.0
63780,,,6268573,[],CHEMBL1804003,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1799937,J Nat Prod,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
63781,,,6268574,[],CHEMBL1804004,Antifungal activity against Candida albicans ATCC 10231 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1799937,J Nat Prod,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1441251,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,128.0
63782,,,6328875,[],CHEMBL1820177,Antimicrobial activity against multidrug-resistant Vibrio parahaemolyticus 7001 after 24 hrs by microtiter plate based MIC assay,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817603,J Nat Prod,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1450333,=,1,1,=,,MIC,ug.mL-1,,0.156,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,,MIC,ug ml-1,UO_0000274,,0.156
63783,,,6332451,[],CHEMBL1820556,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
63784,,,6332452,[],CHEMBL1820557,Antibacterial activity against methicillin-resistant Staphylococcus aureus 08-1 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
63785,,,6332453,[],CHEMBL1820558,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 08-1 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
63786,,,6332454,[],CHEMBL1820559,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 09-4 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
63787,,,6332455,[],CHEMBL1820560,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 09-3 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
63788,,,6332456,[],CHEMBL1820561,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 09-6 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
63789,,,6332457,[],CHEMBL1820562,Antibacterial activity against Streptococcus pneumoniae 08-2 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
63790,,,6332458,[],CHEMBL1820563,Antibacterial activity against Streptococcus pneumoniae 08-4 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
63791,,,6332459,[],CHEMBL1820564,Antibacterial activity against Enterococcus faecium 08-2 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,4.0
63792,,,6332460,[],CHEMBL1820565,Antibacterial activity against Enterococcus faecium 08-7 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,8.0
63793,,,6332461,[],CHEMBL1820566,Antibacterial activity against Enterococcus faecalis 08-10 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
63794,,,6332462,[],CHEMBL1820567,Antibacterial activity against Enterococcus faecalis 08-12 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
63795,,,6332463,[],CHEMBL1820568,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
63796,,,6332464,[],CHEMBL1820569,Antibacterial activity against Escherichia coli 08-21 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
63797,,,6332465,[],CHEMBL1820570,Antibacterial activity against Escherichia coli 08-22 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
63798,,,6332466,[],CHEMBL1820571,Antibacterial activity against Klebsiella pneumoniae 09-22 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
63799,,,6332467,[],CHEMBL1820597,Antibacterial activity against Klebsiella pneumoniae 09-23 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
63800,,,6332468,[],CHEMBL1820572,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
63801,,,6332469,[],CHEMBL1820573,Antibacterial activity against Pseudomonas aeruginosa 09-32 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
63802,,,6332470,[],CHEMBL1820574,Antibacterial activity against Pseudomonas aeruginosa 09-33 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
63803,,,6332471,[],CHEMBL1820575,Antibacterial activity against Pseudomonas aeruginosa 09-34 after 18 to 24 hrs by NCCLS M100-S11 two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1817648,Eur J Med Chem,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451020,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
63804,,active,6962419,[],CHEMBL1794566,PUBCHEM_BIOASSAY: Human Ras-Converting Enzyme Inhibition Assay Measured in Biochemical System Using Plate Reader - 2034-04_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2618],B,,,BAO_0000186,BAO_0000217,biochemical format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1201862,,,"{'bei': '12.14', 'le': '0.23', 'lle': '2.85', 'sei': '5.85'}",CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,4.39,0,http://www.openphacts.org/units/Nanomolar,1212704,=,7,1,=,,AC50,nM,,41000.0,CHEMBL3411,Homo sapiens,Prenyl protein specific protease,9606.0,,,AC50,uM,UO_0000065,,41.0
63805,,inactive,7468762,[],CHEMBL1794440,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],F,,,BAO_0000186,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1201862,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/Nanomolar,1212704,,7,1,,,Potency,nM,,56234.1,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,,Potency,uM,UO_0000065,,56.2341
63806,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7767999,[],CHEMBL1909212,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,IC50,,,,
63807,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768000,[],CHEMBL1909212,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,Ki,,,,
63808,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768001,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,IC50,,,,
63809,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768002,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,Ki,,,,
63810,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768003,[],CHEMBL1909214,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,IC50,,,,
63811,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768004,[],CHEMBL1909214,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,Ki,,,,
63812,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768005,[],CHEMBL1909215,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,IC50,,,,
63813,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768006,[],CHEMBL1909215,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,Ki,,,,
63814,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768007,[],CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63815,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768008,[],CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63816,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768009,[],CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,,IC50,,,,
63817,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768010,[],CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,,Ki,,,,
63818,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768011,[],CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,,IC50,,,,
63819,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768012,[],CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,,Ki,,,,
63820,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768013,[],CHEMBL1909087,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL223,Homo sapiens,Alpha-1d adrenergic receptor,9606.0,,,IC50,,,,
63821,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768014,[],CHEMBL1909087,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL223,Homo sapiens,Alpha-1d adrenergic receptor,9606.0,,,Ki,,,,
63822,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768015,[],CHEMBL1909088,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,IC50,,,,
63823,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768016,[],CHEMBL1909088,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,Ki,,,,
63824,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768017,[],CHEMBL1909089,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,IC50,,,,
63825,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768018,[],CHEMBL1909089,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,Ki,,,,
63826,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768019,[],CHEMBL1909090,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,IC50,,,,
63827,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768020,[],CHEMBL1909090,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,Ki,,,,
63828,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768021,[],CHEMBL1909091,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,IC50,,,,
63829,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768022,[],CHEMBL1909091,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,Ki,,,,
63830,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768023,[],CHEMBL1909092,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,IC50,,,,
63831,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768024,[],CHEMBL1909092,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,Ki,,,,
63832,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768025,[],CHEMBL1909093,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,IC50,,,,
63833,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768026,[],CHEMBL1909093,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,Ki,,,,
63834,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768027,[],CHEMBL1909094,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,IC50,,,,
63835,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768028,[],CHEMBL1909094,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,Ki,,,,
63836,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768029,[],CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,,,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,,IC50,,,,
63837,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768030,[],CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,,,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,,Ki,,,,
63838,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768031,[],CHEMBL1909096,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL4607,Homo sapiens,Angiotensin II type 2 (AT-2) receptor,9606.0,,,IC50,,,,
63839,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768032,[],CHEMBL1909096,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL4607,Homo sapiens,Angiotensin II type 2 (AT-2) receptor,9606.0,,,Ki,,,,
63840,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768033,[],CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,,,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63841,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768034,[],CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,,,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63842,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768035,[],CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63843,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768036,[],CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63844,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768037,[],CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,,,BAO_0000190,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63845,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768038,[],CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,,,BAO_0000192,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63846,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768039,[],CHEMBL1909100,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,IC50,,,,
63847,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768040,[],CHEMBL1909100,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,Ki,,,,
63848,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768041,[],CHEMBL1909101,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL1832,Homo sapiens,Calcitonin receptor,9606.0,,,IC50,,,,
63849,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768042,[],CHEMBL1909101,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL1832,Homo sapiens,Calcitonin receptor,9606.0,,,Ki,,,,
63850,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768043,[],CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63851,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768044,[],CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63852,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768045,[],CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63853,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768046,[],CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63854,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768047,[],CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63855,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768048,[],CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63856,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768049,[],CHEMBL1909122,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,IC50,,,,
63857,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768050,[],CHEMBL1909122,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,Ki,,,,
63858,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768051,[],CHEMBL1909123,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),B,,,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL205,Homo sapiens,Carbonic anhydrase II,9606.0,,,IC50,,,,
63859,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768052,[],CHEMBL1909123,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),B,,,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL205,Homo sapiens,Carbonic anhydrase II,9606.0,,,Ki,,,,
63860,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768053,[],CHEMBL1909124,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL4015,Homo sapiens,C-C chemokine receptor type 2,9606.0,,,IC50,,,,
63861,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768054,[],CHEMBL1909124,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL4015,Homo sapiens,C-C chemokine receptor type 2,9606.0,,,Ki,,,,
63862,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768055,[],CHEMBL1909125,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL2414,Homo sapiens,C-C chemokine receptor type 4,9606.0,,,IC50,,,,
63863,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768056,[],CHEMBL1909125,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL2414,Homo sapiens,C-C chemokine receptor type 4,9606.0,,,Ki,,,,
63864,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768057,[],CHEMBL1909126,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL274,Homo sapiens,C-C chemokine receptor type 5,9606.0,,,IC50,,,,
63865,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768058,[],CHEMBL1909126,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL274,Homo sapiens,C-C chemokine receptor type 5,9606.0,,,Ki,,,,
63866,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768059,[],CHEMBL1909127,DRUGMATRIX: Chemokine CXCR1 (IL-8A),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL4029,Homo sapiens,Interleukin-8 receptor A,9606.0,,,IC50,,,,
63867,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768060,[],CHEMBL1909127,DRUGMATRIX: Chemokine CXCR1 (IL-8A),B,,,BAO_0000192,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL4029,Homo sapiens,Interleukin-8 receptor A,9606.0,,,Ki,,,,
63868,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768061,[],CHEMBL1909128,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL2434,Homo sapiens,Interleukin-8 receptor B,9606.0,,,IC50,,,,
63869,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768062,[],CHEMBL1909128,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL2434,Homo sapiens,Interleukin-8 receptor B,9606.0,,,Ki,,,,
63870,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768063,[],CHEMBL1909129,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,IC50,,,,
63871,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768064,[],CHEMBL1909129,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,Ki,,,,
63872,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768065,[],CHEMBL1909130,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,IC50,,,,
63873,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768066,[],CHEMBL1909130,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,Ki,,,,
63874,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768067,[],CHEMBL1909131,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,IC50,,,,
63875,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768068,[],CHEMBL1909131,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,Ki,,,,
63876,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768069,[],CHEMBL1909132,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,IC50,,,,
63877,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768070,[],CHEMBL1909132,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,Ki,,,,
63878,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768071,[],CHEMBL1909133,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL5282,Homo sapiens,Cytochrome P450 2A6,9606.0,,,IC50,,,,
63879,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768072,[],CHEMBL1909133,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL5282,Homo sapiens,Cytochrome P450 2A6,9606.0,,,Ki,,,,
63880,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768073,[],CHEMBL1909134,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,IC50,,,,
63881,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768074,[],CHEMBL1909134,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,Ki,,,,
63882,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768075,[],CHEMBL1909135,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,IC50,,,,
63883,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768076,[],CHEMBL1909135,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,Ki,,,,
63884,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768077,[],CHEMBL1909136,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,IC50,,,,
63885,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768078,[],CHEMBL1909136,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,Ki,,,,
63886,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768079,[],CHEMBL1909137,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL5281,Homo sapiens,Cytochrome P450 2E1,9606.0,,,IC50,,,,
63887,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768080,[],CHEMBL1909137,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL5281,Homo sapiens,Cytochrome P450 2E1,9606.0,,,Ki,,,,
63888,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768081,[],CHEMBL1909138,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,IC50,,,,
63889,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768082,[],CHEMBL1909138,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Ki,,,,
63890,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768083,[],CHEMBL1909139,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,IC50,,,,
63891,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768084,[],CHEMBL1909139,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,Ki,,,,
63892,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768085,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,IC50,,,,
63893,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768086,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,Ki,,,,
63894,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768087,[],CHEMBL1909141,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,IC50,,,,
63895,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768088,[],CHEMBL1909141,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,Ki,,,,
63896,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768089,[],CHEMBL1909142,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,IC50,,,,
63897,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768090,[],CHEMBL1909142,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,Ki,,,,
63898,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768091,[],CHEMBL1909143,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,IC50,,,,
63899,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768092,[],CHEMBL1909143,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,Ki,,,,
63900,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768093,[],CHEMBL1909144,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,IC50,,,,
63901,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768094,[],CHEMBL1909144,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,Ki,,,,
63902,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768095,[],CHEMBL1909145,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,IC50,,,,
63903,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768096,[],CHEMBL1909145,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,Ki,,,,
63904,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768097,[],CHEMBL1909146,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,IC50,,,,
63905,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768098,[],CHEMBL1909146,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,Ki,,,,
63906,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768099,[],CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63907,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768100,[],CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63908,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768101,[],CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63909,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768102,[],CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63910,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768103,[],CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63911,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768104,[],CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63912,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768105,[],CHEMBL1909150,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,IC50,,,,
63913,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768106,[],CHEMBL1909150,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,Ki,,,,
63914,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768107,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63915,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768108,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63916,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768109,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63917,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770122,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63918,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770123,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63919,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770124,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63920,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770125,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63921,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770126,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63922,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770127,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,IC50,,,,
63923,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770128,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,Ki,,,,
63924,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770129,[],CHEMBL1909156,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,IC50,,,,
63925,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770130,[],CHEMBL1909156,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,Ki,,,,
63926,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770131,[],CHEMBL1909157,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,IC50,,,,
63927,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770132,[],CHEMBL1909157,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,Ki,,,,
63928,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770133,[],CHEMBL1909158,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL402,Homo sapiens,HMG-CoA reductase,9606.0,,,IC50,,,,
63929,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770134,[],CHEMBL1909158,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),B,,,BAO_0000192,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL402,Homo sapiens,HMG-CoA reductase,9606.0,,,Ki,,,,
63930,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770135,[],CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63931,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770136,[],CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63932,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770137,[],CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,,IC50,,,,
63933,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770138,[],CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,,Ki,,,,
63934,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770139,[],CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63935,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770140,[],CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63936,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770141,[],CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63937,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770142,[],CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63938,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770143,[],CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,,,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,,IC50,,,,
63939,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770144,[],CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,,,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,,Ki,,,,
63940,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770145,[],CHEMBL1909164,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL1798,Homo sapiens,Cysteinyl leukotriene receptor 1,9606.0,,,IC50,,,,
63941,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770146,[],CHEMBL1909164,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL1798,Homo sapiens,Cysteinyl leukotriene receptor 1,9606.0,,,Ki,,,,
63942,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770147,[],CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,,,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,,IC50,,,,
63943,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770148,[],CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,,,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,,Ki,,,,
63944,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770149,[],CHEMBL1909166,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,IC50,,,,
63945,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770150,[],CHEMBL1909166,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,Ki,,,,
63946,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770151,[],CHEMBL1909167,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,IC50,,,,
63947,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770152,[],CHEMBL1909167,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,Ki,,,,
63948,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770153,[],CHEMBL1909168,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL4608,Homo sapiens,Melanocortin receptor 5,9606.0,,,IC50,,,,
63949,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770154,[],CHEMBL1909168,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL4608,Homo sapiens,Melanocortin receptor 5,9606.0,,,Ki,,,,
63950,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770155,[],CHEMBL1909169,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,IC50,,,,
63951,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770156,[],CHEMBL1909169,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,Ki,,,,
63952,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770157,[],CHEMBL1909170,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,IC50,,,,
63953,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770158,[],CHEMBL1909170,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,Ki,,,,
63954,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770159,[],CHEMBL1909171,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,IC50,,,,
63955,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770160,[],CHEMBL1909171,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,Ki,,,,
63956,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770161,[],CHEMBL1909172,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,IC50,,,,
63957,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770162,[],CHEMBL1909172,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,Ki,,,,
63958,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770163,[],CHEMBL1909173,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL1821,Homo sapiens,Muscarinic acetylcholine receptor M4,9606.0,,,IC50,,,,
63959,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770164,[],CHEMBL1909173,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL1821,Homo sapiens,Muscarinic acetylcholine receptor M4,9606.0,,,Ki,,,,
63960,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770165,[],CHEMBL1909174,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL2035,Homo sapiens,Muscarinic acetylcholine receptor M5,9606.0,,,IC50,,,,
63961,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770166,[],CHEMBL1909174,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL2035,Homo sapiens,Muscarinic acetylcholine receptor M5,9606.0,,,Ki,,,,
63962,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770167,[],CHEMBL1909175,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,IC50,,,,
63963,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770168,[],CHEMBL1909175,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,Ki,,,,
63964,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770169,[],CHEMBL1909176,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL4018,Homo sapiens,Neuropeptide Y receptor type 2,9606.0,,,IC50,,,,
63965,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770170,[],CHEMBL1909176,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL4018,Homo sapiens,Neuropeptide Y receptor type 2,9606.0,,,Ki,,,,
63966,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770171,[],CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63967,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770172,[],CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63968,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770173,[],CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,,,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,,IC50,,,,
63969,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770174,[],CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,,,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,,Ki,,,,
63970,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770175,[],CHEMBL1909179,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL3464,Mus musculus,"Nitric oxide synthase, inducible",10090.0,,,IC50,,,,
63971,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770176,[],CHEMBL1909179,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",B,,,BAO_0000192,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL3464,Mus musculus,"Nitric oxide synthase, inducible",10090.0,,,Ki,,,,
63972,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770177,[],CHEMBL1909180,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,IC50,,,,
63973,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770178,[],CHEMBL1909180,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,Ki,,,,
63974,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770179,[],CHEMBL1909181,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,IC50,,,,
63975,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770180,[],CHEMBL1909181,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,Ki,,,,
63976,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770181,[],CHEMBL1909182,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,IC50,,,,
63977,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770182,[],CHEMBL1909182,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,Ki,,,,
63978,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770183,[],CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63979,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770184,[],CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63980,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770185,[],CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63981,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770186,[],CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63982,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770187,[],CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63983,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770188,[],CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63984,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770189,[],CHEMBL1909186,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),B,,,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL1827,Homo sapiens,Phosphodiesterase 5A,9606.0,,,IC50,,,,
63985,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770190,[],CHEMBL1909186,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),B,,,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL1827,Homo sapiens,Phosphodiesterase 5A,9606.0,,,Ki,,,,
63986,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770191,[],CHEMBL1909187,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),B,,,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL250,Homo sapiens,Platelet activating factor receptor,9606.0,,,IC50,,,,
63987,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770192,[],CHEMBL1909187,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),B,,,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL250,Homo sapiens,Platelet activating factor receptor,9606.0,,,Ki,,,,
63988,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770193,[],CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,,,BAO_0000190,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63989,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770194,[],CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,,,BAO_0000192,BAO_0000219,cell-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63990,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770195,[],CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
63991,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770196,[],CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
63992,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770197,[],CHEMBL1909190,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL240,Homo sapiens,HERG,9606.0,,,IC50,,,,
63993,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770198,[],CHEMBL1909190,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),B,,,BAO_0000192,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL240,Homo sapiens,HERG,9606.0,,,Ki,,,,
63994,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770199,[],CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,,,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,,IC50,,,,
63995,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770200,[],CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,,,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,,Ki,,,,
63996,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770201,[],CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,,,BAO_0000190,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,,IC50,,,,
63997,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770202,[],CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,,,BAO_0000192,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,,Ki,,,,
63998,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770203,[],CHEMBL1909193,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL4801,Homo sapiens,Caspase-1,9606.0,,,IC50,,,,
63999,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770204,[],CHEMBL1909193,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",B,,,BAO_0000192,BAO_0000357,single protein format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1909046,,,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,Ki,,,,CHEMBL4801,Homo sapiens,Caspase-1,9606.0,,,Ki,,,,
